The growing role of Medicare Advantage in the Medicare program and the changing demographics of Medicare Advantage enrollees have given rise to an interest in how well private plans serve their enrollees relative to traditional Medicare. To answer this question, we build on a previous review of research by examining 62 studies published since 2016 that compare Medicare Advantage and traditional Medicare based on measures of beneficiary experience, affordability, service utilization, and quality.

We found few differences between Medicare Advantage and traditional Medicare that are supported by strong evidence or have been replicated across multiple studies. Both Medicare Advantage and traditional Medicare beneficiaries reported similar rates of satisfaction with their care and overall measures of care coordination. Medicare Advantage outperformed traditional Medicare on some measures, such as use of preventive services, having a usual source of care, and lower hospital readmission rates. However, traditional Medicare outperformed Medicare Advantage on other measures, such as receiving care in the highest-rated hospitals for cancer care or in the highest-quality skilled nursing facilities and home health agencies. Additionally, a somewhat smaller share of traditional Medicare beneficiaries than Medicare Advantage enrollees experienced a cost-related problem, mainly due to lower rates of cost-related problems among traditional Medicare beneficiaries with supplemental coverage. Several studies found lower use of post-acute care among Medicare Advantage enrollees but were inconclusive as to whether that was associated with better or worse outcomes. Findings related to the use of other health care services, including hospital care and prescription drugs, and condition-specific quality of care measures varied – likely due to differences in data and methodology across studies.

When possible, we highlight findings for specific subgroups of interest, such as beneficiaries from communities of color, living in rural areas, or dually eligible for Medicare and Medicaid. Notably, relatively few studies specifically examine these population subgroups, so it is difficult to assess the strength of the findings or how broadly they apply. For example, one study found that Black Medicare beneficiaries had higher rates of potentially avoidable hospitalizations in Medicare Advantage than in traditional Medicare. While important, we could not identify additional analyses that compared the rate of potentially avoidable hospitalizations between Medicare Advantage and traditional Medicare among Hispanic and other beneficiaries of color, beneficiaries living in rural areas, or beneficiaries dually eligible for Medicare and Medicaid. Additionally, despite an increased focus on alternative payment models in Medicare, we only identified two studies that differentiated traditional Medicare beneficiaries attributed to accountable care organizations (ACOs) from traditional Medicare beneficiaries not attributed to ACOs.

Our findings across all measures are summarized below.

Beneficiary Experience

Satisfaction, access to care, care coordination, and experience with prescription drugs: Beneficiaries in Medicare Advantage and traditional Medicare reported similar rates of satisfaction with their care, and similar experiences with wait times, finding a new provider, and overall measures of care coordination. However, Medicare Advantage enrollees were more likely to report having a usual source of care, receiving information during care transitions, and having better experiences getting needed prescription drugs.

Switching: Overall, there were low rates of switching between Medicare Advantage and traditional Medicare, though a slightly larger share of Medicare Advantage enrollees opted to switch from Medicare Advantage to traditional Medicare than beneficiaries who switched from traditional Medicare to Medicare Advantage. Additionally, rates of switching from Medicare Advantage to traditional Medicare were relatively higher among beneficiaries who are dually eligible for Medicare and Medicaid, beneficiaries of color, beneficiaries in rural areas, and following the onset of a functional impairment. Switching rates may be a proxy for dissatisfaction with current coverage arrangements.

Affordability

A somewhat smaller share of beneficiaries in traditional Medicare with supplemental coverage than Medicare Advantage enrollees reported having cost-related problems. Similar findings were observed among Black beneficiaries, beneficiaries under the age of 65, and beneficiaries in fair or poor self-assessed health. Beneficiaries in traditional Medicare with no supplemental coverage had higher rates of cost-related problems than beneficiaries enrolled in Medicare Advantage plans. Three studies examining beneficiaries with high-needs, diabetes, or a mental illness found no differences in affordability-related measures between Medicare Advantage and traditional Medicare.

Utilization

Preventive services: Medicare Advantage enrollees were more likely than beneficiaries in traditional Medicare to receive preventive care services, such as annual wellness visits and routine checkups, screenings, and flu or pneumococcal vaccines, based on several studies, with similar findings for people of color and beneficiaries under age 65.

Hospital Services: Differences in the use of hospital services between people in Medicare Advantage and traditional Medicare varied based on how hospital utilization is measured. Overall, there were generally no differences in the aggregate number of hospital days or average length of stay for common medical admissions, based on evidence from five studies. Four studies found fewer hospital stays among Medicare Advantage enrollees compared to traditional Medicare beneficiaries for at least some groups of beneficiaries. Differences in the share of beneficiaries with at least one hospital stay varied, with two studies finding no differences between Medicare Advantage and traditional Medicare and two studies finding lower rates in Medicare Advantage. No studies examined differences in hospital utilization between Medicare Advantage and traditional Medicare by race and ethnicity or other demographics.

Post-Acute Care: Several studies reported lower rates of skilled nursing facility (SNF), inpatient rehabilitation facility (IRF), and home health use among Medicare Advantage enrollees, and shorter lengths of stay in SNFs and IRFs for Medicare Advantage enrollees than traditional Medicare beneficiaries. Across the seven studies that examined the relationship between post-acute care use, home health use, and patient outcomes, studies generally found lower hospital readmission rates among Medicare advantage users of SNFs and lower hospitalization rates among Medicare Advantage users of home health, but mixed results across other outcomes of care. None of these studies presented results by race and ethnicity or other demographics.

Prescription Drugs: Findings on prescription drug use varied depending on the measure of utilization and condition studied. Three studies found that among specific groups – people with a mental illness, diabetes, Alzheimer’s disease, and high-need beneficiaries (each studied separately) – there were no differences in the use of prescription drugs between Medicare Advantage and traditional Medicare beneficiaries. Two of these studies found that the use of prescription drugs was higher for Medicare Advantage enrollees than traditional Medicare beneficiaries without diabetes and without Alzheimer’s disease. Conversely, another study found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries in stand-alone prescription drug plans to fill at least one prescription for an opioid. None of these studies stratified results by race and ethnicity or other demographic groups.

Physician-administered drugs (i.e., Part B drugs): A single study examined the use of physician-administered drugs and found no difference between Medicare Advantage enrollees and traditional Medicare beneficiaries in the number of injectable drug procedures. Another study found that Medicare Advantage enrollees were more likely than traditional Medicare beneficiaries to receive low-cost Part B drugs in four clinical scenarios where similar or equally effective drugs exist, suggesting that Medicare Advantage coverage may be associated with more efficient prescribing of Part B drugs. These two studies did not present results by race, ethnicity, or other demographics.

Other medical provider and emergency department visits: Medicare Advantage enrollees had fewer medical provider visits overall, but more primary care visits per person, based on four of the six studies we reviewed that compared the number of provider visits between beneficiaries enrolled in Medicare Advantage and traditional Medicare. Emergency department (ED) use was generally similar among Medicare Advantage and traditional Medicare beneficiaries overall, based on one study. A second study that focused on beneficiaries in a single hospital-based delivery system (Banner Health) found that Medicare Advantage enrollees had higher ED visit rates than traditional Medicare attributed to an ACO and traditional Medicare beneficiaries not attributed to an ACO. None of these studies presented results by race, ethnicity, or other demographics.

Quality

Hospital Readmissions: Seven of the 12 studies comparing hospital readmission rates found lower overall readmission rates among Medicare Advantage enrollees than among traditional Medicare beneficiaries. However, four studies that were limited to beneficiaries in a single hospital or beneficiaries undergoing specific procedures, such as knee/hip replacements, found no differences. One study that looked at readmission rates for people with three chronic conditions (myocardial infarction, congestive heart failure, and pneumonia) found higher readmission rates among Medicare Advantage enrollees relative to beneficiaries in traditional Medicare. In two separate studies, Black beneficiaries had higher readmission rates than White beneficiaries in both Medicare Advantage and traditional Medicare.

Potentially avoidable hospitalizations: One study found that Black beneficiaries had higher rates of potentially avoidable hospitalizations for ambulatory care sensitive conditions (ACSCs) in Medicare Advantage than in traditional Medicare. Another study examined rates of hospitalization for ambulatory care sensitive conditions overall and by clinical condition, finding that traditional Medicare beneficiaries were hospitalized more often than Medicare Advantage enrollees for ACSCs; however, this study did not account for differences in the characteristics of Medicare Advantage enrollees and traditional Medicare beneficiaries.

Quality of facility or provider: Five of six studies we reviewed that looked at quality ratings of health care facilities and providers used by Medicare Advantage enrollees and traditional Medicare beneficiaries found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries to receive care in the highest-or lowest-rated hospitals overall or in the highest-rated hospitals for cancer care, skilled nursing facilities (SNFs), and home health agencies. A sixth study examined 18 facility-level quality measures in long-stay nursing homes (i.e., nursing homes) and short-stay nursing homes (i.e., SNFs), finding no differences between Medicare Advantage and traditional Medicare for ten of the measures. However, the remaining eight measures had mixed findings, with Medicare Advantage enrollees having lower risk of antipsychotic drug use while traditional Medicare beneficiaries having lower risk of moderate to severe pain and urinary incontinence.

Disease management (heart disease and diabetes): Findings on disease management varied by condition and quality measure. Among beneficiaries with heart disease, Medicare Advantage enrollees were more likely than those in traditional Medicare to receive guideline-recommended therapies in ambulatory settings, but there were no differences reported in inpatient settings. Additionally, among people with diabetes, Medicare Advantage enrollees were more likely than beneficiaries in traditional Medicare to be prescribed guideline-recommended therapy, use medication for their condition, and perform better on clinical care measures such as diabetic eye exam screening; however, there were no differences in blood sugar control, insulin use, or receipt of blood diabetes tests between Medicare Advantage enrollees and traditional Medicare beneficiaries.

Introduction

Over the last decade, Medicare Advantage enrollment has grown rapidly, rising from 25% of the eligible Medicare population in 2010 to nearly half of the Medicare population in 2022. The Medicare Advantage population has become increasingly diverse, with half of all Black Medicare beneficiaries and 56% of Hispanic beneficiaries enrolled in a Medicare Advantage plan, as of 2019, compared to just over a third of White beneficiaries (37%). Additionally, beneficiaries who are under age 65 with long-term disabilities and beneficiaries who are dually eligible for Medicare and Medicaid account for a growing share of the Medicare Advantage population.

Medicare Advantage plans have several features that may attract enrollees, including an out-of-pocket limit for Medicare-covered services and additional benefits not available under traditional Medicare, such as dental, hearing, and vision benefits. These benefits are often available at little or no extra premium (other than the Part B premium). However, Medicare Advantage plans typically have more limited provider networks. Additionally, there has been growing concern about higher spending on behalf of Medicare Advantage enrollees relative to traditional Medicare beneficiaries. A KFF analysis estimated that federal spending on behalf of Medicare Advantage enrollees was $321 higher per person in 2019 than it would have been if enrollees had instead been covered by traditional Medicare, contributing an estimated $7 billion in additional spending in that year.

The growing role of Medicare Advantage and the relatively high spending on this program raise the question of how well private plans serve their enrollees compared to traditional Medicare. To answer this question, we reviewed 62 studies published between January 1, 2016 and May 1, 2022 that compare Medicare Advantage and traditional Medicare, building on a previous KFF review of research by examining the most recent evidence available on measures of beneficiary experience, affordability, service utilization, and quality.

The studies we reviewed varied widely in terms of methodology, data, and observation years (Appendix Table 1, Appendix Table 2). Notably, relatively few studies looked specifically at beneficiaries from communities of color, beneficiaries living in rural areas, or beneficiaries dually eligible for Medicare and Medicaid. Additionally, despite an increased focus on alternative payment models in Medicare, only two of the studies looked separately at traditional Medicare beneficiaries attributed to accountable care organizations (ACOs). All differences reported in this report are statistically significant (with p-value less than or equal to 0.05) unless noted otherwise. Additionally, studies attempted to account for differences in beneficiary characteristics such as health status and demographics in some fashion, unless noted otherwise. See Appendix Table 2 for more detailed descriptions of these studies, including data sources, methodology, and whether the analysis attempts to account for differences in beneficiary characteristicsBack to top.

Medicare Advantage vs. Traditional Medicare: Literature Review

We identified 62 studies published between January 1, 2016 and May 1, 2022 that used at least one year of data after 2010 and compared Medicare Advantage and traditional Medicare on measures of beneficiary experience, affordability, utilization, or quality. We included studies published in peer-reviewed publications, studies conducted by research and policy organizations, and government reports. The vast majority of studies in our review (49 studies) used data sources that are nationally representative, while six studies used data for a subset of states, one study used administrative data from a single hospital, and six studies used claims or encounter data collected from a single health plan (e.g., Humana), a single health care delivery system (Banner Health), or from a set of hospitals (Appendix Table 2). Just two studies stratified findings for traditional Medicare by whether beneficiaries were attributed to an accountable care organization (ACO).

Ideally, this review would assess differences between Medicare Advantage and traditional Medicare using relatively recent data. However, just 12 of the 62 studies published since 2016 used data from the past five years, while the remaining 50 studies used data from between 2010 and 2017.

Beneficiary experience

We reviewed 16 studies that examined aspects of beneficiaries’ experiences with Medicare Advantage and traditional Medicare, including satisfaction with care (6 studies), access to care (7 studies), care coordination (3 studies), experience with prescription drugs (5 studies), and switching between Medicare Advantage and traditional Medicare (which may be interpreted as an indicator of satisfaction) (4 studies) (Appendix Table 1, Appendix Table 2). Several of these studies overlapped in the measures examined.

Overall, Medicare Advantage enrollees and traditional Medicare beneficiaries reported similar levels of satisfaction with care. With respect to access measures, Medicare Advantage enrollees were more likely to report having a usual source of care, while both groups reported similar experiences with wait times and finding a new provider. Medicare Advantage enrollees and traditional Medicare beneficiaries were similarly satisfied with care coordination overall, but Medicare Advantage enrollees were more likely to report receiving information during care transitions and were somewhat more likely to report a better experience getting needed prescription drugs. Additionally, while switching between the two coverage types was relatively infrequent in either direction, it occurred more often among Medicare Advantage enrollees who opted to disenroll from Medicare Advantage and switch into traditional Medicare, particularly among higher-need beneficiaries.

Satisfaction with care

Five studies found no differences in measures of care satisfaction between Medicare Advantage and traditional Medicare beneficiaries. Overall, the vast majority of Medicare beneficiaries reported being satisfied with their care in both Medicare Advantage and traditional Medicare.¹  One analysis using data from the Medicare Current Beneficiary Survey, found no differences in satisfaction between Medicare Advantage enrollees and traditional Medicare beneficiaries with five aspects of care, including doctor’s concern with overall health, information about medical condition, care by specialist, information obtained by phone, and quality of medical care.²  The analysis did not control for differences in beneficiary demographic, socioeconomic, or health characteristics (Appendix Table 2).

Three additional studies also used data from the Medicare Current Beneficiary Survey to compare satisfaction among beneficiaries with diabetes,³  Alzheimer’s disease,⁴  or mental illness (defined as a presence of any mental disorder or depression)⁵  and found no differences between Medicare Advantage and traditional Medicare in several care satisfaction measures, including satisfaction with quality of medical care and availability of care by specialists. However, the authors of the studies on diabetes and Alzheimer’s disease noted that sample sizes for these two groups may have been too small to detect differences.

A separate study that used data from the Health and Retirement Study found no differences between Medicare Advantage and traditional Medicare in the share that reported being very satisfied with the quality of their care.⁶  This study examined high-need beneficiaries, defined as those with at least three chronic conditions and at least one limitation in activities of daily living (ADLs) or instrumental ADLs, and non-high need beneficiaries.

We were unable to identify studies that compared satisfaction rates for Medicare Advantage and traditional Medicare beneficiaries among other subgroups of the Medicare population, such as by race/ethnicity, age group, Medicare-Medicaid dual eligibility, and rural status.

One study found that experience with care at the end-of-life was rated higher for traditional Medicare than Medicare Advantage. Friends and family reported lower quality end-of-life care for decedents in Medicare Advantage than decedents who had traditional Medicare, even after stratification by hospice enrollment.⁷  Though Medicare Advantage did not cover health care services for people in hospice at the time of the analysis, Medicare Advantage decedents who died in hospice were included because Medicare Advantage plans may play a major role in end-of-life care planning before hospice, guide enrollees to a specific hospice, or oversee other aspects of care.

Access to care

Medicare Advantage enrollees were more likely than traditional Medicare beneficiaries to report having a usual source care. The vast majority of Medicare beneficiaries in both Medicare Advantage and traditional Medicare reported having a usual source of care.^{8 , 9}  The share of Medicare Advantage enrollees who reported having a usual source of care was higher by between 0.9 and 4.0 percentage points depending on the study, year, and data.^{10 , 11 , 12}  Additionally, one study found that Medicare Advantage enrollees were more likely to report a primary care clinician as their regular source of care.¹³ 

Studies that looked at the subset of Medicare beneficiaries who were age 65 and older¹⁴  and studies that looked at the subset of Medicare beneficiaries with long-term disabilities between age 18 and 64 also found that Medicare Advantage enrollees were more likely to report a usual source of care than traditional Medicare beneficiaries in both age groups.¹⁵ 

However, in a study that looked separately at high-needs beneficiaries (those with three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and non-high-needs beneficiaries, there were no differences between Medicare Advantage and traditional Medicare beneficiaries in the share reporting having a usual source of care.¹⁶ 

Among people of color (grouped together), a slightly larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries reported having a usual source of care (91% vs 88%) and a primary care clinician as the source of regular care (79% vs 73%).¹⁷  Due to data limitations, the authors of that one study combined Black, Hispanic, Native American, and Asian/Pacific Islander people into a single category.

Two studies examined the share of Medicare Advantage enrollees and traditional Medicare beneficiaries that reported difficulty getting needed health care, with inconsistent findings. In a nationally-representative study, there were no statistically significant differences between Medicare Advantage and traditional Medicare in the share of beneficiaries reporting difficulty getting needed health care.¹⁸  That study also found no differences between Medicare Advantage and traditional Medicare in the share of beneficiaries reporting that they had a treatment plan for their condition, or that they always or often received an answer about a medical concern the same day they contacted their usual source of care. However, the study did not control for differences in beneficiary case-mix (Appendix Table 2).

Another study examined a subset of beneficiaries in New York, Florida, and California and found that the share of Medicare Advantage enrollees reporting difficulty getting needed care was approximately two percentage points lower than the share of traditional Medicare beneficiaries.¹⁹ 

There was mixed evidence on other measures of access between Medicare Advantage enrollees and traditional Medicare beneficiaries. Medicare Advantage enrollees were more likely to report having a health care professional they could easily contact in between doctor visits, but reported similar wait times as beneficiaries in traditional Medicare for outpatient and physician office visits.²⁰  Additionally, there were no differences in the share of Medicare Advantage and traditional Medicare beneficiaries reporting trouble finding a general doctor, being told that their health insurance was not accepted, and being told they would not be accepted as a new patient.²¹  A separate study also found no differences between Medicare Advantage and traditional Medicare in the share of beneficiaries reporting difficulty finding a provider, for both the subset of beneficiaries with high-needs (those with three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and without high-needs. ²² 

A fourth study that looked at Medicare beneficiaries with cancer in their last year of life found that those in traditional Medicare were more likely than those in Medicare Advantage to report excellent experience getting care quickly and getting needed care.²³ 

Care coordination

Medicare Advantage enrollees and traditional Medicare beneficiaries reported similar experiences on measures of care coordination overall. Two studies compared measures of care coordination in Medicare Advantage and traditional Medicare and found no differences between beneficiaries in either group.^{24 , 25}  Additionally, one of these studies found no differences in the share of beneficiaries reporting that their regular doctor always or often helps coordinate care with other providers.²⁶ 

A larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries reported specific care management practices in one study. Compared to traditional Medicare beneficiaries, a larger share of Medicare Advantage enrollees reported that their health care professional had discussed with them their main goals or priorities in caring for their condition (76% versus 60%, respectively) or had given them given them clear instructions about symptoms to monitor in caring for their condition after returning home from the hospital (97% versus 90%, respectively).²⁷  The study did not control for differences in beneficiary demographic, socioeconomic, or health characteristics (Appendix Table 2).

That same study also compared measures of care coordination among beneficiaries with three or more chronic conditions or limitations in activities of daily living (defined in the study as “high need”) and beneficiaries with diabetes.²⁸  Among these subgroups, there were no statistically significant differences between beneficiaries in Medicare Advantage and traditional Medicare in the share reporting that their regular doctor always or often helps coordinate care with other providers. However, consistent with the overall findings, among these subgroups a larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries reported that their health care professional had discussed with them their main goals or priorities in caring for their condition.

Another study found that among the subgroups of beneficiaries with high-needs (those with three or more chronic conditions and an ADL or an instrumental ADL) and without high-needs, there were no differences between beneficiaries in Medicare Advantage and traditional Medicare in the share reporting that their preferences were usually or always taken into account.²⁹ 

Experience with prescription drugs

Medicare Advantage enrollees reported better experiences getting needed prescription drugs than traditional Medicare beneficiaries overall, but among beneficiaries with specific conditions, findings were mixed. Five studies examined experiences with prescription drugs among beneficiaries in Medicare Advantage and traditional Medicare (Appendix Table 1, Appendix Table 2). In a study of Medicare beneficiaries in California, New York, and Florida, a larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries reported that they were satisfied with their experience getting needed prescription drugs (91.4% in Medicare Advantage vs 87.3% in traditional Medicare).³⁰  Another analysis found that compared to traditional Medicare beneficiaries in stand-alone prescription drug plans (PDPs), enrollees in Medicare Advantage prescription drug plans (MA-PDs) reported greater ease obtaining medications (90.1% vs. 87.9%, respectively), less difficulty getting coverage information (81.2% vs. 78.2%, respectively) and less difficulty getting cost information (80.4% vs. 78.9%, respectively).³¹ 

A third study found that a larger share of Medicare Advantage enrollees (91%) than traditional Medicare beneficiaries (84%) reported having a health care professional review their medications in the past year.³²  However, among beneficiaries with diabetes, mental health conditions, or cancer, this same study reported that differences between beneficiaries in Medicare Advantage and traditional Medicare were not statistically significant. While the analysis compared the experiences of beneficiaries with certain health conditions, it did not further control for differences in beneficiary characteristics (Appendix Table 2).

A study that examined beneficiaries with a mental illness found no differences between Medicare Advantage and traditional Medicare on satisfaction with list of prescriptions covered.³³ 

The fifth analysis found that among Medicare beneficiaries with cancer in their last year of life, those in traditional Medicare were more likely than those in Medicare Advantage to report excellent experience getting needed prescription drugs.³⁴ 

Switching between Medicare Advantage and Traditional Medicare

Medicare beneficiaries can make a change in their coverage by switching from traditional Medicare to a Medicare Advantage plan (or vice versa) during the Medicare Open Enrollment period each year. Other beneficiaries, such as those dually eligible for Medicare and Medicaid and beneficiaries in certain institutions, such as nursing homes, may switch coverage more frequently. Researchers use rates of disenrollment or switching as a proxy measure for satisfaction with Medicare coverage.

We identified four studies that examined switching in both directions (Medicare Advantage to traditional Medicare and traditional Medicare to Medicare Advantage) using at least one year of data since 2010. Of these four studies, two did not control for differences in beneficiary case-mix or health risk, including one study that presented descriptive statistics without statistical testing (Appendix Table 1, Appendix Table 2). These four studies found that overall, there were low rates of switching between Medicare Advantage and traditional Medicare; however, there were higher rates of switching from Medicare Advantage to traditional Medicare among beneficiaries who are dually eligible for Medicare and Medicaid, beneficiaries of color, beneficiaries in rural areas, and following the onset of a functional impairment. Authors of these studies discussed several factors that could explain differences in switching among certain beneficiaries, including networks in some plans that beneficiaries with complex care needs may deem restrictive; however, studies did not determine the specific reasons beneficiaries switched their source of Medicare coverage.

Beneficiaries who are dually eligible for Medicare and Medicaid, particularly those with high health needs, and beneficiaries of color had relatively high levels of switching between traditional Medicare and Medicare Advantage. One study examining beneficiaries dually eligible for Medicare and Medicaid found that these beneficiaries switched between Medicare Advantage and traditional Medicare at a higher rate than non-dual-eligible beneficiaries, regardless of the direction of switching.³⁵  These findings may in part be attributable to the fact that dually eligible beneficiaries are able to switch plans once per calendar quarter in the first three quarters of the year, in addition to the open enrollment period. In addition, high-need dual-eligible beneficiaries were more likely to disenroll from Medicare Advantage to traditional Medicare than dual-eligible beneficiaries who were not classified as high need. In comparison, a smaller share of high-need dual-eligible beneficiaries who were enrolled in traditional Medicare switched to Medicare Advantage than non-high need dual eligible beneficiaries.

Another study looked at beneficiaries’ enrollment decisions after the onset of a functional impairment and found that beneficiaries of color were more likely to switch sources of Medicare coverage than White beneficiaries regardless of whether they started with Medicare Advantage or traditional Medicare.³⁶  Specifically, beneficiaries of color accounted for 24% of the Medicare Advantage population in the study’s sample but 47% of Medicare Advantage enrollees who switched from Medicare Advantage to traditional Medicare. In comparison, beneficiaries of color accounted for 15% of the study’s traditional Medicare population and 21% of traditional Medicare beneficiaries who switched from traditional Medicare to Medicare Advantage. Authors of the study were unable to report switching patterns for individual racial and ethnic groups separately due to sample size and data reporting restrictions. Additionally, due to sample size limitations, the analysis was precluded from using multivariable regression models to examine factors that were independently associated with switching (Appendix Table 2). It is possible that higher rates of switching among beneficiaries of color may reflect the fact that a relatively large share of Black and Hispanic beneficiaries are dually eligible for Medicare and Medicaid, and therefore able to switch more frequently during the year.

A study of beneficiaries living in rural areas found that a larger share of rural beneficiaries switched from Medicare Advantage to traditional Medicare than switched from traditional Medicare to Medicare Advantage. One study found that among beneficiaries in rural areas, the rate of switching from Medicare Advantage to traditional Medicare (10.7%) was higher than the rate of switching from traditional Medicare to Medicare Advantage (1.7%).³⁷  Among beneficiaries in non-rural areas, the difference in switching rates between beneficiaries in Medicare Advantage and traditional Medicare was narrower, but the rates were still higher among those switching from Medicare Advantage to traditional Medicare (4.6%) than those switching from traditional Medicare to Medicare Advantage (2.2%).

Few studies have examined patterns of switching among beneficiaries with complex health needs, with one study finding that after the onset of functional impairments, a larger share of beneficiaries in Medicare Advantage switched to traditional Medicare compared to the share of beneficiaries in traditional Medicare that switched to Medicare Advantage. One of the four studies described above found that following the onset of a functional impairment, beneficiaries ages 65 and older were more likely to switch from Medicare Advantage to traditional Medicare than from traditional Medicare to Medicare Advantage.³⁸  Specifically, following the onset of a functional impairment, the rate of switching from Medicare Advantage to traditional Medicare was 65.6 switches per 1,000 person-years, while the rate of switching from traditional Medicare to Medicare Advantage was 44.4 switches per 1,000 person-years. Due to sample size limitations, the analysis was precluded from using multivariable regression models to examine factors that were independently associated with switching (Appendix Table 2).

The fourth study presented descriptive statistics on switching by people with newly-diagnosed diseases or conditions but did not test whether observed differences were statistically significant.³⁹  The authors found that overall, the rate of switching for this group from traditional Medicare to Medicare Advantage (4.1%) was higher than the rate of switching from Medicare Advantage to traditional Medicare (2.2%). This pattern held for most newly-diagnosed diseases and conditions in the analysis, such as Alzheimer’s disease and related dementias, hypertension, and cancer. However, among beneficiaries newly diagnosed with stroke, the rate of switching from traditional Medicare to Medicare Advantage (2.2%) was slightly lower than the rate of switching from Medicare Advantage to traditional Medicare (2.6%).

Affordability

We identified seven studies that compared affordability-related difficulties among beneficiaries in Medicare Advantage and traditional Medicare (Appendix Table 1, Appendix Table 2). These studies generally found that a somewhat larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries experienced a cost-related problem, mainly due to lower rates of cost-related problems among traditional Medicare beneficiaries with supplemental coverage. These studies found that traditional Medicare beneficiaries without supplemental coverage had the most affordability-related difficulties.

Medicare Advantage enrollees who are Black, under age 65 with disabilities, or in fair or poor health were more likely to report cost-related problems than their traditional Medicare counterparts.  Few differences were found among beneficiaries with high-needs, a mental illness, or diabetes.

Traditional Medicare beneficiaries reported fewer cost-related problems than enrollees in Medicare Advantage, mainly driven by traditional Medicare beneficiaries with supplemental insurance. Two studies compared reports of cost-related problems between Medicare Advantage enrollees, traditional Medicare beneficiaries with supplemental insurance, and traditional Medicare beneficiaries without supplemental insurance. The first study examined the share of each group that reported trouble getting care due to cost, a delay in care due to cost, or problems paying medical bills, and found that the share reporting at least one cost-related problem was somewhat lower among beneficiaries in traditional Medicare overall (15%) and traditional Medicare with supplemental coverage (12%) than among Medicare Advantage enrollees (19%).⁴⁰  The rate of cost-related problems was highest among traditional Medicare beneficiaries without supplemental coverage (30%). These findings held after controlling for income, race and ethnicity, Medicaid dual status, and health status.

Similarly, another analysis found that among adults ages 65 and older, the share reporting problems paying medical bills was higher among Medicare Advantage enrollees (8.3%) than among those in traditional Medicare with private supplemental coverage (5.6%).⁴¹  Again, a smaller share of both groups reported problems than among traditional Medicare beneficiaries with no supplemental coverage (12.4%). The analysis did not control for differences in beneficiary characteristics such as income. Two additional studies looked at ability to get needed health care or delays in care due to cost among Medicare Advantage and traditional Medicare beneficiaries, without breaking out traditional Medicare beneficiaries with and without supplemental coverage. One of these analyses found that in 2009, Medicare Advantage enrollees were slightly more likely than beneficiaries in traditional Medicare to report delaying care for cost reasons; however, in 2017, differences between Medicare Advantage and traditional Medicare were not significant.⁴²  The other study did not find statistically significant differences in the share of Medicare Advantage enrollees and traditional Medicare beneficiaries reporting trouble getting health care because of high cost, though the analysis did not control for differences in beneficiary characteristics (Appendix Table 2).⁴³ 

One study found that traditional Medicare beneficiaries report fewer cost-related problems than enrollees in Medicare Advantage when focusing on beneficiaries who are Black, under age 65 with disabilities, or in relatively poor health. One of the seven studies described above stratified results by race and ethnicity, age, and self-reported health status.⁴⁴  The study found that among Black beneficiaries, beneficiaries under the age of 65, and beneficiaries in fair or poor self-assessed health, a smaller share of beneficiaries in traditional Medicare reported cost-related problems compared to enrollees in Medicare Advantage plans after adjusting for various beneficiary characteristics.

Three studies examining beneficiaries with high-needs or specific conditions found some differences in affordability-related measures between Medicare Advantage and traditional Medicare. The first study looked at beneficiaries with high needs (i.e., those with three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and non-high needs beneficiaries, finding no statistically significant differences between Medicare Advantage and traditional Medicare in the share of beneficiaries unable to afford care. ⁴⁵ 

The second study examined measures of affordability among beneficiaries with a mental illness. This study found no differences between Medicare Advantage and traditional Medicare in care dissatisfaction with out-of-pocket costs for prescription drugs, delay in getting prescription drugs due to cost, and inability to get prescription drugs due to cost.⁴⁶  However, enrollment in Medicare Advantage increased dissatisfaction with out-of-pocket expenses for medical care by 25.5 percentage points. That study further identified beneficiaries with depression specifically, finding that differences in dissatisfaction with out-of-pocket expenses for medical care among beneficiaries with mental illness were largely driven by beneficiaries with depression.

The third study examined beneficiaries with and without diabetes and found no differences between Medicare Advantage and traditional Medicare in the share of beneficiaries with diabetes who were satisfied with out-of-pocket costs for medical care.⁴⁷  However, Medicare Advantage enrollees without diabetes were slightly less likely to report satisfaction with out-of-pocket costs for medical care than traditional Medicare beneficiaries without diabetes.

Utilization

We reviewed 34 studies that compared the use of health care services between Medicare Advantage enrollees and traditional Medicare beneficiaries, including preventive services (7 studies), hospital care (15 studies), post-acute care and home health (18 studies), prescription drugs (5 studies), and other services (8 studies) (Appendix Table 1, Appendix Table 2).  Several of these studies overlapped in the measures examined. The analyses consistently found that Medicare Advantage enrollees had higher utilization of preventive services and lower utilization of post-acute care and home health services. Findings related to the use of hospital care, prescription drugs, and other services were mixed, with the variation likely due in part to differences in how outcome measures were defined, methodology and data. Just two studies analyzed utilization of health care services among demographic subgroups of the Medicare population, finding that among beneficiaries of color and beneficiaries under the age of 65, utilization of preventive services was greater for Medicare Advantage enrollees, consistent with the overall pattern of preventive services utilization.

Utilization of preventive services

Seven studies compared receipt of preventive care services among beneficiaries in Medicare Advantage and traditional Medicare (Appendix Table 1, Appendix Table 2). These studies examined vaccination rates for flu, pneumonia, and shingles and the receipt of several preventive screenings, finding that Medicare Advantage enrollees were more likely than traditional Medicare beneficiaries to receive these preventive services, overall and among beneficiaries of color and beneficiaries under age 65.

Larger shares of Medicare Advantage enrollees reported having an annual wellness visit or routine checkup than beneficiaries in traditional Medicare. Two studies compared rates of annual wellness visits or routine checkups between Medicare Advantage and traditional Medicare. Both found a larger share of Medicare Advantage enrollees reported a routine checkup⁴⁸  or annual wellness visit, with Medicare Advantage enrollees also more likely to report that the annual wellness visit included a cognitive assessment.⁴⁹  The authors of the study that found higher rates of cognitive assessments in annual wellness visits among Medicare Advantage enrollees acknowledged that drawing on data from an online panel may not capture people with severe cognitive impairments.⁵⁰ 

Medicare Advantage enrollees had higher rates of vaccinations than traditional Medicare beneficiaries. Three studies examined overall flu vaccination rates and found a larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries received their annual flu vaccine.^{51 , 52 , 53}  The difference in the shares of Medicare Advantage enrollees and traditional Medicare beneficiaries receiving the flu vaccine ranged from 2.2% to 3.5%.^{54 , 55}  One of these studies also compared receipt of pneumonia vaccines and found higher rates in Medicare Advantage than traditional Medicare, with a difference of 2.0% between the two coverage types.⁵⁶ 

An analysis that focused more narrowly on patients with heart failure found no statistically significant differences in receipt of flu or pneumococcal vaccinations between beneficiaries in Medicare Advantage and traditional Medicare.⁵⁷ 

In a separate analysis looking at shingles vaccinations, a larger share of Medicare Advantage enrollees in prescription drug plans (MA-PDs) did not fill prescribed shingles vaccines (8.9%) compared to traditional Medicare beneficiaries in stand-alone prescription drug plans (PDPs) (6.4%).⁵⁸  The analysis was limited to beneficiaries ages 65 and older and did not specify how it accounted for any differences in receiving the shingles vaccine before enrolling in Medicare.

Despite the disproportionate impact of COVID-19 pandemic on Medicare beneficiaries, we were unable to identify studies meeting our inclusion criteria that examined COVID-19 vaccination rates by Medicare coverage group as of May 1, 2022.

Medicare Advantage enrollees reported higher rates of several preventive screening services. A larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries reported colorectal and breast cancer screenings and blood pressure screening.^{59 , 60 , 61}  For instance, the difference between Medicare Advantage and traditional Medicare in the share receiving colorectal cancer screening was 4.4 percentage points in one of these studies.⁶²  One study also found higher rates of cholesterol management among Medicare Advantage (95%) enrollees compared to traditional Medicare beneficiaries (87%),⁶³  while another found no differences in this measure.⁶⁴ 

Utilization of preventive service by race and ethnicity mirrored overall differences between Medicare Advantage and traditional Medicare. Patterns of flu and pneumonia vaccination were similar in a study that examined White beneficiaries; Black, Hispanic, Native American, and Asian and Pacific Islander beneficiaries (examined as a single group); and Black beneficiaries (examined separately). In this study, a higher share of beneficiaries of color in Medicare Advantage (67.3%) than in traditional Medicare (63.0%) reported receiving the flu vaccine.⁶⁵  Similarly, a larger share of beneficiaries of color in Medicare Advantage (70.7%) than in traditional Medicare (64.6%) reported receiving a pneumonia vaccine. The study also presented results for Black beneficiaries separately from other groups, finding a similar pattern. However, the authors acknowledged that due to sample size limitations, they were unable to present disaggregated data for Hispanic, Native American, or Asian/Pacific Islander beneficiaries.

Among beneficiaries under the age of 65, utilization of preventive services was greater for Medicare Advantage enrollees, based on evidence from one study. Only one study examined the use of preventive services for people under 65 with long-term disabilities. Consistent with the overall patterns of preventive services utilization, the study found that among beneficiaries under the age of 65, Medicare Advantage enrollees were more likely to report receiving cholesterol and colon cancer screenings and flu vaccinations.⁶⁶  We were unable to identify studies that analyzed preventive services utilization among beneficiaries dually eligible for Medicaid or beneficiaries in rural areas.

Hospital utilization

Fifteen studies compared measures of hospital utilization between Medicare Advantage enrollees and beneficiaries in traditional Medicare (Appendix Table 1, Appendix Table 2), including the share of beneficiaries with at least one hospital stay (4 studies), the number of hospitals stays (4 studies), the average length of stay (3 studies), the total number of hospital days (2 studies), and hospitalizations near the end of life (3 studies) (some studies included multiple measures). Findings were mixed and varied based on the particular measure of utilization.

Studies examining the share of beneficiaries with at least one hospital stay had mixed findings, with two studies finding no difference between Medicare Advantage and traditional Medicare and two studies finding lower rates in Medicare Advantage. Two studies found no difference in the share of Medicare Advantage enrollees and traditional Medicare beneficiaries with at least one hospital stay.^{67 , 68}  One of these studies did not control for differences in beneficiary demographic, socioeconomic, or health characteristics (Appendix Table 2).⁶⁹  A separate study found that among high-needs beneficiaries (those with three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and non-high-needs beneficiaries, a smaller share of Medicare Advantage enrollees reported at least one hospital stay than traditional Medicare beneficiaries.⁷⁰  Another study examined a single health delivery system, Banner Health, which partnered with Blue Cross Blue Shield of Arizona to provide a Medicare Advantage plan and also operated an Accountable Care Organization (ACO) in one county in Arizona. This study found that the Medicare Advantage enrollees had lower hospitalization rates compared to traditional Medicare beneficiaries, both those who were attributed to the Banner ACO and the non- Banner, non-ACO beneficiaries.⁷¹ 

The number of hospital stays was lower in Medicare Advantage plans than in traditional Medicare for some groups of beneficiaries. Four studies found fewer hospital stays among Medicare Advantage enrollees compared to traditional Medicare beneficiaries for at least some groups of beneficiaries. One study examined differences in inpatient hospital admissions for Medicare beneficiaries with and without Alzheimer’s disease and related dementias (ADRD), finding slightly fewer hospitalizations among Medicare Advantage enrollees in both groups compared to traditional Medicare beneficiaries.⁷²  Specifically, among beneficiaries with ADRD, those in Medicare Advantage had 0.3 inpatient hospital admissions a year compared to 0.47 for those in traditional Medicare. The study used an instrumental variable design in an effort to address concerns about adverse selection into Medicare Advantage by healthier beneficiaries and controlled for other observable beneficiary characteristics (Appendix Table 2).

A second study examined changes in hospital use following transition from commercial insurance (prior to Medicare enrollment) to Medicare Advantage or traditional Medicare with supplemental insurance (through Aetna) and found that enrollment in Medicare Advantage was associated with a larger reduction in the number of inpatient stays.⁷³  This suggests that the use of hospital services is lower in Medicare Advantage than in traditional Medicare. The study only followed beneficiaries for a single year after enrollment in Medicare and used data from a single insurer, Aetna, so findings may not be generalizable to the broader Medicare population, though the strong quasi-experimental design of the analysis is useful in isolating the effects of payer type for the group studied.

A third study looked at hospital admissions for beneficiaries with and without diabetes. The study found that among people with diabetes, Medicare Advantage enrollees had 0.1 fewer inpatient hospital stays per year on average than traditional Medicare beneficiaries.⁷⁴  In the same study there were no differences between Medicare Advantage and traditional Medicare beneficiaries in number of inpatient hospital stays for people without diabetes.

The fourth study found that among both high-needs beneficiaries (those with three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and non-high-needs beneficiaries, Medicare Advantage enrollees had fewer hospital stays than traditional Medicare beneficiaries, and the difference between Medicare Advantage and traditional Medicare beneficiaries was larger among high-needs beneficiaries than non-high needs beneficiaries (2.1 fewer inpatient stays versus 0.6 stays, respectively).⁷⁵ 

An additional study examined inpatient hospital admissions among beneficiaries with a mental illness, finding no differences in number of inpatient hospital admissions between Medicare Advantage and traditional Medicare. ⁷⁶ 

Differences in the length of inpatient hospital stays between Medicare Advantage enrollees and traditional Medicare beneficiaries varied by type of admission. One study, based on a subset of beneficiaries in 28 states, found comparable lengths of stay for medical admissions, the most frequent type of admission. Medicare Advantage enrollees had shorter lengths of stay for mental health and longer lengths of stay for injury and surgical admissions.⁷⁷  At the time of the analysis, the 28 states included in the sample accounted for 75 percent of all Medicare Advantage enrollees.

A second analysis, based on a subset of 18 states, presented descriptive statistics for the 20 most common types of admissions. With the exception of admissions for respiratory failure, where the average length of stay was shorter among Medicare Advantage enrollees (7.2 days) than traditional Medicare beneficiaries (8.2 days), the average lengths of stay for the remaining 19 admissions were similar between Medicare Advantage enrollees and traditional Medicare beneficiaries (a difference of less than 0.3 days on average), though statistical tests were not included in the report.⁷⁸ 

A third study examined patients who underwent total hip and knee arthroplasty using claims data from a single insurer. The analysis found no difference in the length of stay for Medicare Advantage enrollees and traditional Medicare beneficiaries but did not include adjustments for differences in beneficiary characteristics.⁷⁹ 

The number of total hospital days did not differ between Medicare Advantage and traditional Medicare. Two studies included the number of hospital days per 1,000 beneficiaries, a measure that combines the number of admissions and length of stay. Neither study found a difference between Medicare Advantage and traditional Medicare after adjusting for beneficiary characteristics.^{80 , 81} 

Hospitalizations at the end-of-life were somewhat more common in traditional Medicare than in Medicare Advantage. One study calculated descriptive statistics for the site of death for Medicare beneficiaries and found that a smaller share of Medicare Advantage decedents were hospitalized during the last 30 and 90 days of their lives compared to decedents who were in traditional Medicare.⁸²  Another study looked specifically at people with dementia and found that a smaller share of decedents who had Medicare Advantage were hospitalized in the last 30 days of life compared to traditional Medicare beneficiaries, including those attributed to an Accountable Care Organization (ACO).⁸³   A third study found no differences between Medicare Advantage and traditional Medicare in hospital admissions in the last 30 days of life. ⁸⁴ 

We were unable to identify studies that examined any measures of hospital utilization between Medicare Advantage and traditional Medicare that stratified by different demographic subgroups, such as by age group, dual eligibility, and race/ethnicity.

Post-acute And Home Health care utilization

Eighteen studies examined utilization of home health care and post-acute care services in skilled nursing facilities (SNFs), long-stay nursing homes, and inpatient rehabilitation facilities (IRFs) (Appendix Table 1, Appendix Table 2). Ten of these studies evaluated utilization of post-acute care services in SNFs and other nursing homes, or IRFs, with most finding fewer days of care or shorter length of stays among Medicare Advantage enrollees compared to traditional Medicare beneficiaries. Eleven studies included an examination of the use of home health care, with a majority finding somewhat lower use among Medicare Advantage enrollees than traditional Medicare beneficiaries. Several studies overlapped in the type of post-acute care setting examined.

Medicare Advantage enrollees used fewer skilled nursing facility and inpatient rehabilitation services than traditional Medicare beneficiaries. Ten studies examined post-acute care received in institutional settings (e.g., nursing homes, SNFs, and IRFs) and seven of these studies found lower utilization among Medicare Advantage enrollees compared to traditional Medicare beneficiaries. These studies mostly examined discharges following hospitalizations for specific sets of conditions and looked at the likelihood of being admitted to a SNF or IRF, as well the average length of stay.

Four studies compared SNF use overall. The first found that Medicare Advantage enrollees had substantially fewer days of SNF care (2,337 days per 1,000 beneficiary-years) than beneficiaries in traditional Medicare (2,902 days per 1,000 beneficiary-years)—a difference of 565 days per 1,000 beneficiary-years, with greater geographic variation in the number of SNF days among enrollees in Medicare Advantage than in traditional Medicare.⁸⁵  The analysis controlled for demographic characteristics, as well as the number of limitations in activities of daily living and differences in cognitive function, but according to the authors, data limitations precluded a more robust adjustment for beneficiary health status (Appendix Table 1).

However, two studies that stratified beneficiaries by health needs found no differences in the use of SNFs between Medicare Advantage enrollees and traditional Medicare beneficiaries, for both the subsets of beneficiaries with or without Alzheimer’s disease and related dementias (ADRD)⁸⁶  or the subsets of beneficiaries with or without high needs (i.e., three or more chronic conditions and limitations in activities of daily living (ADLs) or instrumental ADLs).⁸⁷ 

A fourth study compared SNF use by enrollees in a Medicare Advantage plan operated by Banner Health and Blue Cross Blue Shield, traditional Medicare beneficiaries attributed to an ACO operated by Banner Health since 2012, and traditional Medicare beneficiaries in the same county (Maricopa, Arizona) not attributed to the ACO. The study found that in 2012 and 2013, Medicare Advantage enrollees had fewer days of care in a SNF than traditional Medicare beneficiaries, including both Banner ACO beneficiaries and non-ACO beneficiaries; however, in 2014, differences between Medicare Advantage and traditional Medicare beneficiaries who were not attributed to the Banner ACO were not statistically significant.⁸⁸  The study also examined SNF use in the two years preceding ACOs (2010-2011) by comparing Medicare Advantage enrollees, the cohort of traditional Medicare beneficiaries who were eventually assigned to an ACO in 2012, and the cohort of traditional Medicare beneficiaries who were not attributed to an ACO in 2012. The authors found fewer days of care among Medicare Advantage enrollees than the traditional Medicare groups.

We identified three studies that examined the use of post-acute care following hospitalizations for high-volume conditions, including joint replacement, stroke, and heart failure, and these studies found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries to be discharged to a SNF or IRF.^{89 , 90 , 91}  Once admitted to an IRF, Medicare Advantage enrollees received fewer days of care in these facilities.⁹²  Shorter lengths of stays in SNFs and fewer minutes of rehabilitation care were also found following hospitalization for hip fracture for Medicare Advantage enrollees compared to beneficiaries in traditional Medicare.⁹³ 

One analysis of patients undergoing total hip and knee arthroplasty at a single institution found no difference in the likelihood of being discharged to a SNF following the procedure between Medicare Advantage enrollees and traditional Medicare beneficiaries.⁹⁴ 

Studies examining outcome measures for users of skilled nursing facilities found lower hospital readmission rates among Medicare advantage enrollees, but inconsistent findings on other outcome measures. Four studies, including one that followed a subset of beneficiaries hospitalized for joint replacement, stroke, and heart failure, examined outcome measures among users of skilled nursing facilities. These studies found that Medicare Advantage enrollees had lower hospital readmission rates and higher rates of return to the community and did not observe poorer outcomes (e.g., changes in functional status) relative to beneficiaries in traditional Medicare.^{95 , 96 , 97}  However, one of the four studies found that among short-stay (i.e., SNF) residents, Medicare Advantage enrollees had lower rates of new or worsening pressure ulcers but higher rates of moderate to severe pain than traditional Medicare beneficiaries.⁹⁸  In addition, that same study found that among long-stay residents (i.e., people with nursing home stays that extended beyond 100 days), Medicare Advantage enrollees had higher rates of urinary incontinence than traditional Medicare beneficiaries.

Most studies found utilization of home health was lower among Medicare Advantage enrollees than traditional Medicare beneficiaries. Eleven studies examined utilization of home health care in Medicare Advantage and traditional Medicare. Eight of these studies found that Medicare Advantage enrollees had lower utilization of home health care services and three studies found no differences between beneficiaries in Medicare Advantage and traditional Medicare, either overall,⁹⁹  or among subsets of beneficiaries with and without diabetes¹⁰⁰  or Alzheimer’s disease and related dementias (ADRD).¹⁰¹ 

Six of the eight studies that found lower utilization of home health services among Medicare Advantage enrollees included an examination of the share of patients starting home health following discharge from the hospital.^{102 , 103 , 104 , 105 , 106 , 107}  These studies found that Medicare Advantage enrollees were less likely to have a home health visit, and the findings were consistent across studies with various methodological approaches and strategies for addressing differences in beneficiary health status (see Appendix Table 1 and Appendix Table 2 for more detail). The share of enrollees receiving home health services ranged from 2.4% to 6.0% lower in Medicare Advantage compared to traditional Medicare. Additionally, while use of home health was consistently lower in Medicare Advantage, one study that examined trends found that the rates of home health use appeared to be converging over time.¹⁰⁸ 

The seventh study compared high-needs beneficiaries (those with three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and non-high-needs beneficiaries found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries to use home health care among both high-needs and non-high needs beneficiaries; however, the magnitude of the differences between Medicare Advantage and traditional Medicare beneficiaries was larger among high-needs beneficiaries (5.5 percentage point difference) than non-high needs beneficiaries (1.5 percentage point difference).¹⁰⁹ 

The eighth study looked specifically at home health use among patients with cancer, finding that Medicare Advantage enrollees had lower rates of home health use and shorter lengths of home health care than traditional Medicare beneficiaries.¹¹⁰  While the study presented unadjusted differences that did not account for differences in beneficiary characteristics (Appendix Table 2), the results were consistent with overall findings from other studies that examined utilization of home health services.

Four of these eight studies also examined the duration of home health services and consistently found that Medicare Advantage enrollees had fewer days of home health use than traditional Medicare beneficiaries.^{111 , 112 , 113 , 114}  Traditional Medicare beneficiaries had between 7.1 and 19.3 more days of home health days than Medicare Advantage enrollees, depending on the study.

Studies examining outcome measures for users of home health services found lower hospitalization rates among Medicare Advantage enrollees, but inconsistent findings on other outcome measures. Three studies examined whether home health users had different rates of hospitalization in Medicare Advantage and traditional Medicare, finding lower rates of hospitalization among Medicare Advantage enrollees. Two of these studies, however, have notable limitations that may have confounded the findings. The first study controlled for measures like functional status, but not health status because this information was not available in the data for Medicare Advantage enrollees (Appendix Table 2).¹¹⁵  The second study did not account for the duration of home health and because traditional Medicare beneficiaries had longer home health episodes, they had more opportunities to be admitted to the hospital while receiving home health services.¹¹⁶  Additionally, the third used Medicare Advantage data from a single insurer which covered about 20% of the Medicare Advantage population at the time of the study, potentially limiting generalizability to the broader Medicare Advantage population.¹¹⁷ 

In addition, one of the studies looked at additional outcome measures among home health users. This study found that Medicare Advantage enrollees fared better with respect to dyspnea (trouble breathing), while traditional Medicare beneficiaries fared better with respect to improvements in pain.¹¹⁸ 

None of the studies that examined use of post-acute care among Medicare Advantage and traditional Medicare beneficiaries included findings by race and ethnicity or other demographic subgroups (Appendix Table 1). Of the 18 studies in our review that examined receipt of post-acute care services in institutionalized (SNF, nursing home, and IRF) settings and home health, we were unable to identify any studies that stratified utilization estimates by both coverage type and demographic subgroups such as race and ethnicity, age group, Medicare-Medicaid dual eligibility, and rural status, though some examined beneficiaries by condition.

Utilization of other services and prescription drugs

Ten studies examined utilization of other services, including outpatient and physician visits (6 studies), emergency department visits (2 studies), and prescription drugs (5 studies) (Appendix Table 1, Appendix Table 2). Three studies overlapped in measures examined. These studies had mixed findings depending on the measure used.

Evidence on differences in outpatient and physician visits between Medicare Advantage enrollees and traditional Medicare beneficiaries was mixed. One study compared the number of primary care visits per person, defined as visits to providers in family medicine, internal medicine, pediatric medicine, and general practice specialties. The study found that Medicare Advantage enrollees had more primary care visits per person than traditional Medicare beneficiaries.¹¹⁹ 

A second study examined changes in physician visits following transition from commercial insurance to either a Medicare Advantage plan (Aetna) or traditional Medicare with an Aetna supplemental insurance (i.e., Medigap) plan, finding that enrollment in Medicare Advantage was not associated with a statistically significant change in number of physician visits compared to traditional Medicare.¹²⁰  This suggests that use of physician services is similar between Medicare Advantage enrollees and traditional Medicare beneficiaries in the year following initial enrollment in Medicare.

Three studies examined utilization of medical practitioner visits, procedures, services, and supplied items among beneficiaries with and without diabetes or Alzheimer’s disease and related dementias (ADRD) and beneficiaries with any mental illness, finding that Medicare Advantage enrollees had lower utilization of these services than traditional Medicare beneficiaries.^{121 , 122 , 123}  Among those with diabetes, Medicare Advantage enrollees had 22.4 fewer of these services than traditional Medicare beneficiaries; among those without diabetes, Medicare Advantage enrollees had 12.5 fewer of these services than traditional Medicare beneficiaries. Similarly, Medicare Advantage enrollees with ADRD had 22.3 fewer of these services than traditional Medicare beneficiaries with ADRD, and Medicare Advantage enrollees without ADRD had 15.0 fewer of these services compared to similar traditional Medicare beneficiaries. Among beneficiaries with any mental illness, Medicare Advantage enrollees had 36.48 fewer of these services than traditional Medicare beneficiaries. The studies on diabetes and ADRD excluded beneficiaries under the age of 65 and all three studies excluded beneficiaries whose original Medicare eligibility was attributable to end-stage renal disease.

A sixth study examined the number of physician visits and the share of beneficiaries with any physician visits among beneficiaries with high-needs (i.e., those with three or more chronic conditions and a limitation in activities of daily living (ADLs) or instrumental ADLs) and those without high-needs. That study found that among high-needs beneficiaries, Medicare Advantage enrollees had a 2.5 percentage point lower probability of having any physician visits; however, differences in the number of physician visits were not statistically significant.¹²⁴  The study looked separately at those without high-needs, finding no difference in the share of beneficiaries with any physician visits, but a 1.8 percentage point reduction in number of physician visits among Medicare Advantage enrollees than traditional Medicare beneficiaries.

One of the six studies described above also examined outpatient hospital visits among beneficiaries with a mental illness, finding that Medicare Advantage enrollment was associated with 6.73 fewer outpatient hospital visits relative to traditional Medicare.¹²⁵ 

Only two studies examined use of emergency department visits among Medicare Advantage and traditional Medicare beneficiaries, yielding mixed results. We identified just two studies that analyzed differences in emergency department visits. One study found similar shares of Medicare Advantage and traditional Medicare beneficiaries age 65 and older with an emergency department visit (34% for both groups).¹²⁶  The study did not control for differences in beneficiary characteristics (Appendix Table 2). The second study examined a single hospital-based delivery system (Banner Health) that partnered with Blue Cross Blue Shield to offer a Medicare Advantage plan and beginning in 2012, participated in the Pioneer ACO program. This study found that in 2013 and 2014, the Medicare Advantage enrollees had higher emergency department visit rates than traditional Medicare attributed to the Banner-ACO and traditional Medicare beneficiaries not attributed to an ACO.¹²⁷ 

Utilization of drugs administered by physicians and other health care providers (i.e., drugs that are covered under Medicare Part B that are typically used to treat cancer and other serious conditions) was similar between Medicare Advantage and traditional Medicare, though Medicare Advantage was associated with more efficient use. One study found that upon transitioning from commercial insurance to an Aetna Medicare Advantage or traditional Medicare with an Aetna Medigap policy, there were no differences in the number of injectable drug procedures between the two groups.¹²⁸  A second study found that Medicare Advantage enrollees were more likely to receive low-cost Part B drugs in four clinical scenarios where similar or equally effective drugs exist, suggesting that Medicare Advantage coverage may be associated with more efficient prescribing of Part B drugs.¹²⁹ 

Studies comparing differences in prescription drug utilization among Medicare Advantage and traditional Medicare beneficiaries found inconsistent evidence. Five studies examined differences in utilization of prescription drugs among beneficiaries in Medicare Advantage and traditional Medicare.

Three studies found no statistically significant differences in use of prescription drugs among beneficiaries with a mental illness, diabetes, or Alzheimer’s disease and related dementias (ADRD) in Medicare Advantage plans or traditional Medicare,^{130 , 131 , 132}  but among beneficiaries without diabetes or ADRD, Medicare Advantage enrollees filled 27.6 and 19.4 more prescriptions than traditional Medicare beneficiaries, respectively. These studies did not specify the type of prescription drug purchases, including whether the drugs were brand or generic drugs.

Another study examined prescribing and utilization patterns related to opioids finding Medicare Advantage Prescription Drug (MA-PD) enrollees were less likely to fill a prescription for an opioid compared to traditional Medicare beneficiaries in stand-alone prescription drug plans (PDPs).¹³³  The analysis accounted for beneficiary age, gender, and race, as well as characteristics of the county and local health care market but did not control for beneficiary-level health risk (Appendix Table 2).

The fifth study found no statistically significant differences in prescription drug use among Medicare Advantage and traditional Medicare beneficiaries with high-needs (i.e., three or more chronic conditions and a limitation in ADLs or instrumental ADLs) and among non-high needs beneficiaries.¹³⁴ 

None of the studies that examined any measures of prescription drug or other service utilization stratified results by different demographic groups. Of the ten studies that examined utilization of outpatient and physician visits, emergency department visits, prescription drugs, and Part B drugs, none presented estimates by both Medicare coverage types and demographic subgroups such as race and ethnicity, age group, Medicare-Medicaid dual eligibility, and rural status.

Quality

We reviewed 27 studies that compared Medicare Advantage and traditional Medicare on aspects of quality, including hospital readmission rates (12 studies), potentially avoidable hospitalizations (2 studies), quality rating of facilities (6 studies), disease management (7 studies), and use of low-value care (1 study), including one study that overlapped in measures examined (Appendix Table 1, Appendix Table 2). Overall, neither Medicare Advantage nor traditional Medicare consistently performed better across all measures

Hospital readmissions

Twelve studies in our review compared hospital readmission rates between Medicare Advantage and traditional Medicare (Appendix Table 1, Appendix Table 2). Seven of these studies generally found lower rates in Medicare Advantage than traditional Medicare. Four studies that were more limited in scope found similar rates of readmission between traditional Medicare and Medicare Advantage and one study examining three conditions (acute myocardial infarction, congestive heart failure, pneumonia) included in the Hospital Readmissions Reduction Program (HRRP) found higher readmission rates among Medicare Advantage enrollees relative to beneficiaries in traditional Medicare. Additionally, while Black beneficiaries had higher readmission rates than White beneficiaries in both Medicare Advantage than traditional Medicare, there was a wider difference between Black and White patients in Medicare Advantage plans.

Readmission rates were generally lower in Medicare Advantage than in traditional Medicare. Of the seven studies that found lower readmission rates among Medicare Advantage enrollees, ^{135 , 136 , 137 , 138 , 139 , 140 , 141}  two studies focused on patients discharged to skilled nursing facilities (SNFs) after their initial hospitalization^{142 , 143}  and two studies followed patients hospitalized for a subset of chronic conditions.^{144 , 145}  One analysis focused on beneficiaries ages 65 and over who were hospitalized in one of 66 hospitals in a single state (WI), finding that readmission rates were lower among Medicare Advantage enrollees than beneficiaries in traditional Medicare within the same hospital for 62 out of 66 hospitals.¹⁴⁶  Two studies examined readmission rates among beneficiaries in a subset of states that covered less than a third of the Medicare Advantage population, so findings may not be generalizable to the broader Medicare population.^{147 , 148} 

Four studies found similar rates of hospital readmissions between Medicare Advantage and traditional Medicare,^{149 , 150 , 151 , 152}  though only one of these studies included a sample that was relatively broad. The study found no differences for readmissions for five conditions (acute myocardial infarction, pneumonia, heart failure, stroke and hip or knee replacement), with slightly lower readmissions for one condition, chronic obstructive pulmonary disease, among Medicare Advantage enrollees (17.8%) than traditional Medicare beneficiaries (18.7%).¹⁵³  The three other studies that found no difference in hospital readmission rates were based on a single hospital,¹⁵⁴  claims from one insurer for hip or knee replacements,¹⁵⁵  or six surgical procedures in a single state.¹⁵⁶ 

One study that was national in scope found that Medicare Advantage enrollees had higher risk-adjusted readmission rates compared to beneficiaries in traditional Medicare.¹⁵⁷  The analysis looked specifically at patients with acute myocardial infarction, congestive heart failure, and pneumonia. The authors found that the pattern of higher readmission rates among Medicare Advantage enrollees held when comparing beneficiaries admitted to the same hospital.

Black beneficiaries were more likely to be readmitted to the hospital than White beneficiaries in both Medicare Advantage and traditional Medicare. Two studies examined readmission rates between Medicare Advantage and traditional Medicare stratified by race. The first focused on patients who were initially discharged to a skilled nursing facility.¹⁵⁸  The second was based on a sample of patients undergoing at least one of six surgical procedures in hospitals in the state of New York.¹⁵⁹  In both studies, Black beneficiaries had higher rates of 30-day hospital readmissions than White beneficiaries in both traditional Medicare and Medicare Advantage. However, the studies had inconsistent findings with respect to whether the disparity was greater in traditional Medicare or Medicare Advantage: in the study of patients initially discharged to a skilled nursing facility, the differences between Black and White beneficiaries were similar for both traditional Medicare and Medicare Advantage,¹⁶⁰  but in the study of patients undergoing surgical procedures in New York,¹⁶¹  Black traditional Medicare beneficiaries were 33 percent more likely than White traditional Medicare beneficiaries to be readmitted, while Black Medicare Advantage enrollees were 64 percent more likely than White Medicare Advantage enrollees to be readmitted. While these studies examined disparities between White and Black beneficiaries in Medicare Advantage and traditional Medicare, they did not separately compare differences between Medicare Advantage and traditional Medicare within each individual racial group.

We were unable to identify additional studies that stratified readmission estimates by other demographic subgroups such as by Medicare-Medicaid dual eligibility and rural status.

Potentially avoidable hospitalizations

Hospitalizations for ambulatory care sensitive conditions (ACSC) are considered potentially avoidable if appropriate care has been provided in a primary care setting. The rate of hospitalizations for ACSCs are therefore used as an indicator for quality. Two studies examined the rate of these potentially avoidable hospitalizations among Medicare Advantage enrollees and traditional Medicare beneficiaries. However, only one of these studies accounted for differences in the characteristics of Medicare Advantage enrollees and traditional Medicare beneficiaries. After controlling for beneficiary characteristics, Black beneficiaries had higher rates of potentially avoidable hospitalizations in Medicare Advantage than in traditional Medicare.

Traditional Medicare beneficiaries had higher rates of hospitalization for ACSCs in a study that did not control for age or health status differences. One study found that traditional Medicare beneficiaries were hospitalized more often than Medicare Advantage enrollees for ACSCs.¹⁶²  The study did not evaluate statistical significance or adjust beneficiary characteristics (Appendix Table 2).

Black Medicare Advantage enrollees had higher rates of potentially avoidable hospitalizations for ACSCs than Black traditional Medicare beneficiaries. One study compared hospitalizations for ACSCs between Black and White beneficiaries in Medicare Advantage and traditional Medicare.¹⁶³  After controlling for differences in demographic characteristics and chronic conditions, this study found that Black Medicare Advantage enrollees were more likely to be hospitalized for ACSCs (221.2 ACSCs per 10,000 beneficiaries) than Black traditional Medicare beneficiaries (209.3 ACSCs per 10,000 beneficiaries), but there were no differences between White Medicare Advantage enrollees and White traditional Medicare beneficiaries.

Disparities between Black and White beneficiaries in rates of potentially avoidable hospitalizations for ACSCs were larger in Medicare Advantage than traditional Medicare. In addition to finding differences between Medicare Advantage and traditional Medicare for Black, but not White beneficiaries, this same study found that the differences between Black and White beneficiaries were larger in Medicare Advantage than traditional Medicare (59.0 ACSCs per 10,000 beneficiaries in Medicare Advantage compared to 45.6 ACSCs per 10,000 beneficiaries in traditional Medicare). Further, differences between Black and White Medicare Advantage enrollees were present in nearly all hospital markets, while differences between Black and White beneficiaries in traditional Medicare were observed in just over half of the geographic areas.¹⁶⁴ 

Quality of facilities

Six studies compared the quality of facilities used by beneficiaries in Medicare Advantage and traditional Medicare (Appendix Table 1, Appendix Table 2). These studies generally found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries to receive care from the highest or lowest rated hospitals overall, or highest-rated hospitals for cancer care, skilled nursing facilities, and home health agencies.   

Two studies found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries to receive care from higher-rated hospitals. Two studies examined the quality of admitting hospitals specifically. One study found that Medicare Advantage enrollees were more likely to be admitted to average-quality hospitals rather than either high- or low-quality hospitals for non-emergent conditions; differences for emergency conditions were not significant.¹⁶⁵  The study also examined the quality of hospitals for rural beneficiaries in Medicare Advantage and traditional Medicare, finding no difference between the two coverage types. The second study found that Medicare Advantage enrollees were less likely than beneficiaries in traditional Medicare to use a top-ranked cancer hospital for five cancer-related surgical procedures.¹⁶⁶ 

Two studies found that Medicare Advantage enrollees were less likely to receive care from the highest-quality home health agencies and skilled nursing facilities. Two studies examined the quality ratings of home health agencies and found that Medicare Advantage enrollees were less likely than traditional Medicare beneficiaries to receive care from high-quality home health providers.^{167 , 168}  Another study found that Medicare Advantage enrollees were more likely to enter nursing homes with lower quality ratings and higher rehospitalization rates compared to beneficiaries in traditional Medicare, after controlling for clinical conditions and facility-level characteristics.¹⁶⁹ 

The sixth study examined 18 facility-level quality measures in long-stay nursing homes (i.e., nursing homes) and short-stay nursing homes (i.e., SNFs), finding no differences between Medicare Advantage and traditional Medicare for ten of the measures. However, the remaining eight measures had inconsistent findings: while Medicare Advantage enrollees in SNFs and long-stay nursing homes had lower risk of antipsychotic drug use, traditional Medicare beneficiaries in SNFs and long-stay nursing homes had lower risk of moderate to severe pain and urinary incontinence, respectively.¹⁷⁰ 

Disease management

Seven studies examined measures of disease management or quality of care for specific diseases, including heart disease, diabetes, and end-stage renal disease (Appendix Table 1, Appendix Table 2). These three disease areas are of interest because of their prevalence or cost. Nearly a third (32%) of all Medicare beneficiaries have heart disease and about a third (34%) have diabetes. While people with end-stage renal disease accounted for about 1% of the total Medicare population in 2019, they represent a disproportionate share of Medicare spending. These studies had mixed findings depending on the condition and quality measure.

Medicare Advantage enrollees with heart disease were more likely than traditional Medicare beneficiaries to receive guideline-recommended therapies in ambulatory settings, but not during an inpatient admission. One study, using data from patients who were hospitalized for heart failure, found no statistically significant differences between traditional Medicare and Medicare Advantage across most quality measures, such as receipt of guideline-recommended therapies.¹⁷¹  A second analysis of patients with coronary heart disease in the ambulatory setting found that Medicare Advantage enrollees were more likely to receive guideline-recommended secondary prevention treatment (i.e., statins), but there were no significant differences in intermediate outcomes (e.g., systolic and diastolic blood pressure) between beneficiaries in Medicare Advantage and traditional Medicare.¹⁷² 

The authors of these two studies note that differences in findings for ambulatory versus inpatient settings could be partially attributed to the way Medicare Advantage plans negotiate contracts with providers in these two settings. Specifically, because ambulatory clinicians negotiate contracts directly with Medicare Advantage plans, which may include quality benchmarks, clinicians in this setting are incentivized to provide better quality of care. While similar quality contracts exist in the inpatient hospital setting, inpatient physicians may be unaware of the specifics of the contract, limiting plans’ influence in incentivizing inpatient physicians’ practice.

Four studies comparing quality and experiences with care among beneficiaries with diabetes in Medicare Advantage and traditional Medicare had mixed findings. One analysis of adults ages 65 and older with diabetes found a larger share of Medicare Advantage than traditional Medicare beneficiaries with diabetes “had medication use” (72.7% versus 62.5%) but Medicare Advantage enrollees were less likely to have a blood sugar test (70.3% versus 79.7%) or a test for average blood sugar level over the past three months (HbA1C) (86.6% versus 93.9%).¹⁷³  The study found no significant differences on five other process measures of diabetes care, including whether blood sugar was well controlled, insulin use, blood pressure check at home, comprehensive foot exam, and checks for sores on feet. That study also found no differences between traditional Medicare and Medicare Advantage in care satisfaction, general health status, or change in health status among diabetic beneficiaries.

A second study found that Medicare Advantage enrollees were more likely than beneficiaries in traditional Medicare to be prescribed guideline-recommended therapy for diabetes.¹⁷⁴  The study also found that traditional Medicare beneficiaries were more likely to be treated with medications from newer drug classes, which could represent higher quality of care but also more costly treatment (as these medications do not yet have generic alternatives). The scope of the study did not include process measures of diabetes care, such as whether blood sugar was well controlled.

A third study found that among beneficiaries in three states (CA, FL, NY), Medicare Advantage had higher levels of performance than traditional Medicare on clinical quality measures of diabetes care, including diabetic eye exam screening, diabetic cholesterol screening, and nephropathy care.¹⁷⁵ 

The fourth study looked at measures of diabetes management by race and ethnicity, finding that while White beneficiaries had higher rates of foot examinations, flu shots, and cholesterol checks than Hispanic beneficiaries in both Medicare Advantage and traditional Medicare, the disparity between White and Hispanic beneficiaries was narrower in Medicare Advantage than in traditional Medicare.¹⁷⁶ 

Medicare beneficiaries with end-stage renal disease (ESRD) in one Medicare Advantage Special Needs Plan (SNP) had lower mortality and lower utilization than traditional Medicare beneficiaries. Prior to 2021, beneficiaries with ESRD were not able to enroll in most Medicare Advantage plans, with the exception of some SNPs. Therefore, we were only able to identify one study that compared the quality of care received by beneficiaries with ESRD in traditional Medicare versus Medicare Advantage SNPs.¹⁷⁷  The study found that enrollees with ESRD in a SNP had lower all-cause mortality and lower utilization across the care continuum compared to beneficiaries with ESRD in traditional Medicare. Because the analysis was limited to beneficiaries in a single health plan, CareMore Health, in three counties in California, findings may not be generalizable to other ESRD SNPs or Medicare Advantage plans more broadly.

Findings from one study on other measures of disease management indicate higher levels of performance for Medicare Advantage than traditional Medicare. The study found that Medicare Advantage had higher levels of performance on three measures of disease management, with variation in the magnitude of differences by type of measure.¹⁷⁸  Specifically, Medicare Advantage outperformed traditional Medicare by 8.7 percentage points on a measure of rheumatoid arthritis management and as much as 23.9 percentage points on a measure of osteoporosis management for fractures. Similarly, with respect to medication adherence, Medicare Advantage plans performed better than traditional Medicare.

Low-value care

Low-value care is defined as services that provide little clinical benefits to patients but have potential to cause harm or incur health care costs for certain population groups. One study identified 13 low-value services from prior research and categorized them in four composite measures of low-value cancer screening, antibiotic use, medication, and imaging use (Appendix Table 1, Appendix Table 2). This study compared use of low-value care services between beneficiaries in Medicare Advantage and traditional Medicare, finding no statistically significant differences between the two groups in use of most of these services; however, a larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries had low-value medication use.

One study found no statistically significant differences between Medicare Advantage and traditional Medicare beneficiaries in use of low-value cancer screenings, antibiotic use, or imaging services under certain circumstances. The study categorized screening for cervical, colorectal, and prostate cancer for specific groups under the composite measure of low-value cancer screening, finding no significant differences in use between Medicare Advantage and traditional Medicare beneficiaries.¹⁷⁹  Cancer screenings were considered “low-value” if, for example, men age 75 and older without a diagnosis of prostate cancer received a prostate-specific antigen test. The study found similar findings for low-value antibiotic use (e.g., antibiotic for influenza among individuals diagnosed with influenza but without a diagnosis of bacterial infection, chronic obstructive pulmonary disease, or cancer) and low-value imaging services (e.g., MRI or CT for headache for individuals with a diagnosis of headache but no diagnosis of pregnancy, cancer, or epilepsy).

That same study found that a larger share of Medicare Advantage enrollees than traditional Medicare beneficiaries have used at least one medication under circumstances where use of these medications is considered low-value. Specifically,19.7% of Medicare Advantage enrollees in certain circumstances received low-value medications compared to 17.6% of beneficiaries in traditional Medicare.¹⁸⁰  Examples of circumstances where medications were considered “low-value” include use of opioids for back pain among individuals with a diagnosis of back pain but no diagnosis of fever or cancer.

Authors of the study were unable to measure all potentially relevant exclusions when identifying use of low-value care, so it is possible that for some of the people who received these services, care was indicated based on risk factors that could not be identified in the data and was therefore not low-value.

This study did not stratify results by race and ethnicity, dual eligibility status, or other demographic groups.Back to top.

Data and Methods for Comparing Medicare Advantage and Traditional Medicare

Analyses use a variety of data sources to compare Medicare Advantage and traditional Medicare. The vast majority of studies we reviewed (49 out of 62 studies) used nationally-representative data sources (Appendix Table 1), including the Medicare Current Beneficiary Survey (MCBS), Medicare Consumer Assessment of Healthcare Providers & Systems (MCAHPS), Medicare Provider Analysis and Review, long-term care Minimum Data Set, and national registries of patients with certain clinical characteristics. Six studies used state-level datasets, such as Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases, and one study used administrative data from a single hospital. The remaining six studies used claims or encounter data collected from a single health plan (Humana, Aetna, or Blue Cross Blue Shield) that covered beneficiaries within the plan nationally or a subset of beneficiaries in a single state, a single health delivery system, or in multiple hospitals. Notably, lags in data availability, and the sometimes-lengthy peer-review process means that only 12 studies used data from the past five years, while the remaining used data from between 2010 and 2017 (Appendix Table 2). The data period is important because the Affordable Care Act made substantial changes to how Medicare Advantage plans are paid, which were not fully phased in for several years after that legislation was enacted into law, and so their effects may not be captured by studies that use older data.

Of the 62 studies in our review, just two studies used Medicare Advantage encounter data. Most studies relied on sources such as the MCBS and Healthcare Effectiveness Data and Information Set (HEDIS) to identify utilization of services among Medicare Advantage enrollees. While many of these data sources have been routinely used to examine outcomes of interest, they lack the type of information on specific service utilization that is contained in claims data. For example, the authors of one study noted they were unable to identify enrollees with all chronic conditions in their analysis of disenrollment among beneficiaries with complex chronic conditions due to incomplete encounter data.¹⁸¹  Ideally, data that is comparable to traditional Medicare’s claims data would be used to compare utilization between Medicare Advantage and traditional Medicare beneficiaries, controlling for demographic, geographic, diagnostic and other variables. However, the Medicare Payment Advisory Commission (MedPAC) has identified several concerns with the quality of Medicare Advantage encounter data, the only multi-payer source of claims across all Medicare Advantage plans currently available to researchers, including data incompleteness and attribution of enrollees to the wrong plan. In addition, differences in coding intensity across Medicare Advantage and traditional Medicare complicate comparisons using claims data. These concerns limit the types of analyses that can be reliably conducted using these data.

Most, but not all, studies attempted to account for differences in beneficiary characteristics, including differences in health status. Of the 62 studies in our review, most (52 studies) attempted to account for differences in the characteristics of beneficiaries in Medicare Advantage and traditional Medicare, including demographic, socioeconomic, and health risks, though they varied in methodology and transparency (Appendix Table 1, Appendix Table 2). Fifty studies were explicit in how they adjusted for health risk, and typically acknowledged that they could not completely address selection bias due to unobservable characteristics between beneficiaries in Medicare Advantage and traditional Medicare.

The use of more sophisticated statistical methods varied. The majority of studies included regression models to estimate the difference between beneficiaries in Medicare Advantage and traditional Medicare, controlling for observable beneficiary characteristics. Several studies created matched samples (using propensity score matching to select traditional Medicare beneficiaries that were most similar to Medicare Advantage enrollees) or included inverse probability of treatment weights (IPTW) in the regression model as a further attempt to adjust for differences in the likelihood of certain groups to enroll in Medicare Advantage (versus traditional Medicare) (Appendix Table 1, Appendix Table 2).

A small number of studies (7 studies) used a quasi-experimental design, such as difference-in-differences and instrumental variable approach, to isolate the effect of enrollment in Medicare Advantage on outcomes of interest (Appendix Table 1, Appendix Table 2). For example, one study examined changes in health care utilization upon transitioning from commercial insurance for people who enrolled in Medicare Advantage compared to those who enrolled in traditional Medicare.¹⁸²  These study designs help to address concerns about differential selection into Medicare Advantage.Back to top.

Gaps in Research

Despite the growth in enrollment of beneficiaries of color, few studies presented estimates for Medicare Advantage and traditional Medicare beneficiaries by race and ethnicity. Of the 62 studies in our review that compared measures of beneficiary experience, affordability, utilization, and quality between Medicare Advantage and traditional Medicare, seven studies compared estimates by race and ethnicity. These gaps in data for certain subgroups of Medicare beneficiaries is especially concerning given that about half of all Black and Hispanic Medicare beneficiaries are now enrolled in a Medicare Advantage plan. The seven studies that compared estimates by race and ethnicity were unable to present more nuanced and disaggregated data that reflect the heterogeneity within different racial and ethnic groups: three studies were limited to comparisons between Black, White and Hispanic beneficiaries; two studies compared non-Hispanic Black and White beneficiaries; and two studies combined into a single category Black, Hispanic, Native American and Asian/Pacific Islander people, without reporting separately for each of these groups.

Just two studies in our review compared estimates by Medicare-Medicaid dual status. This is despite the fact that 12.3 million people on Medicare also have coverage under Medicare and Medicaid, and a growing share—now 36%—of this group are enrolled in a Medicare Advantage plan. While a portion of this population are enrolled in Medicare-Medicaid plans offered under the financial alignment demonstration, evaluations of which are not included in this review, the majority are in other Medicare Advantage plans. People who are dually eligible for Medicare and Medicaid are low-income and tend to have significant health needs. The two studies that did compare quality of care between Medicare Advantage and traditional Medicare by dual status focused on switching patterns (Medicare Advantage to traditional Medicare and traditional Medicare to Medicare Advantage) rather than other direct indicators of quality of care.

Most studies in our review excluded beneficiaries under age 65 and other groups with significant health needs. Seven million people on Medicare were under age 65 and living with disabilities in 2019, and 39% of this group was enrolled in a Medicare Advantage plan. However, just two studies in our review examined estimates for beneficiaries under age 65. Most studies in our review (33 studies) excluded beneficiaries under age 65 specifically.

In addition, only one study examined the experience of people with end-stage renal disease. This is a very vulnerable population, who is now permitted to enroll in individual Medicare Advantage plans, due to a recent change in law. Monitoring the experiences of those with ESRD will be important, especially with respect to whether they have access to dialysis facilities under MA plans.

Few studies examined measures of beneficiary experiences, affordability, utilization, and quality of care among traditional Medicare and Medicare Advantage beneficiaries in rural areas. More than one in four Medicare beneficiaries living in rural areas are enrolled in a Medicare Advantage plan. However, we were able to identify just two studies that examined differences between Medicare Advantage and traditional Medicare beneficiaries in rural versus urban areas.  While Medicare Advantage enrollment is lower in rural than urban areas, according to MedPAC, Medicare Advantage enrollment has grown faster in rural areas.

While there has been an increased focus on alternative payment models in Medicare, the 62 studies in our review generally did not evaluate Accountable Care Organizations (ACO) or other alternative payment and care delivery models in traditional Medicare separately when comparing traditional Medicare to Medicare Advantage. According to MedPAC, 10.7 million Medicare beneficiaries are attributed to 477 accountable care organizations under the Medicare Shared Savings Program. However, just two studies stratified the traditional Medicare population by ACO attribution.

Only three studies examined Medicare Advantage Special Needs Plan (SNPs) separately from other Medicare Advantage enrollees when comparing estimates to traditional Medicare. Medicare Advantage SNPs provide targeted care to a disproportionately high-need population, including enrollees with severe or disabling chronic conditions, enrollees dually eligible for Medicaid, or enrollees in institutional settings. However, just three studies in our review stratified results for Medicare Advantage enrollees by SNP status.

None of the 62 studies in our review examined measures related to COVID-19, including rates of vaccinations, hospitalizations, and deaths between Medicare Advantage and traditional Medicare beneficiaries. The COVID-19 pandemic has had a disproportionate impact on older adults, virtually all of whom are covered by Medicare. However, we were unable to find analyses that met our inclusion criteria that compared the experiences of traditional Medicare and Medicare Advantage enrollees with respect to COVID-19 hospitalizations, post-acute care, vaccination rates, and deaths as of May 2022. Our inability to find other studies that examined COVID-19 vaccination rates specifically is likely due to the lag in data availability, incompleteness of claims data for measuring COVID-19 vaccine administration, and a sometimes lengthy peer-review process, as only one study in our review included data that overlapped with the pandemic.Back to top.

Conclusion

Together, these 62 studies provide further insight to compare Medicare Advantage and traditional Medicare, though with somewhat mixed and inconclusive evidence. Beneficiaries in Medicare Advantage and traditional Medicare reported similar rates of satisfaction with their care, experiences with wait times, finding a new provider, and overall measures of care coordination. Enrollees in Medicare Advantage plans were more likely to report having a usual source of care and receiving preventive services such as annual wellness visits and the flu vaccine. Medicare Advantage enrollees also had lower utilization of skilled nursing facilities and home health care, as well as lower hospital readmission rates, but they were less likely than traditional Medicare beneficiaries to receive care in hospitals, skilled nursing facilities, and home health agencies with the highest quality ratings. Additionally, Medicare Advantage enrollees who were admitted to skilled nursing facilities following discharge from the hospital had lower hospital readmission rates, though evidence on other outcome measures was inconsistent. Medicare Advantage enrollees from communities of color reported higher rates of preventive care service use, consistent with the overall pattern; however, two studies also found that Black enrollees in particular experienced higher rates of avoidable hospitalizations and hospital readmissions compared to Black beneficiaries in traditional Medicare, and that disparities in rates of avoidable hospitalizations and hospital readmission between Black and White beneficiaries were greater in Medicare Advantage than in traditional Medicare. Beneficiaries in traditional Medicare were less likely to report affordability problems than Medicare Advantage enrollees, mainly due to supplemental coverage.

Our findings are consistent with a 2021 systematic review of the literature that found that Medicare Advantage enrollees had higher utilization of preventive care visits, fewer skilled nursing facility stays, and were more likely to receive care in average-quality hospitals and lower-quality skilled nursing facilities and home health agencies. While our review, limited to data since 2010, generally finds lower hospital readmission rates among Medicare Advantage enrollees, the other literature review, which includes data spanning back to 2003, did not find a consistent pattern in readmission rates relative to traditional Medicare. Our review is broader in scope in that it includes studies that examine affordability measures, patterns of switching between Medicare Advantage and traditional Medicare, experiences with prescription drugs, and utilization of prescription drugs (i.e., Part D) and drugs administered by physicians or other healthcare providers (i.e., Part B).

A 2014 KFF review of studies published between 2000 and 2014 also documented that Medicare Advantage plans scored higher than traditional Medicare on indicators of preventive care services. However, while our 2022 review finds lower hospital readmission rates among Medicare Advantage enrollees, the 2014 review found that the evidence on hospital readmission rates was inconclusive, likely due to few studies that accounted for differences in beneficiary characteristics at that time. Notably, both the 2014 review and this 2022 review continue to document data constraints, including limited insight into the experiences of certain beneficiaries, such as beneficiaries with more complex medical needs.

As Medicare Advantage plans continue to have an expanding role in the Medicare program, the studies in our review provide useful context for understanding how well Medicare Advantage plans are serving their enrollees relative to traditional Medicare. At the same time, data limitations remain a significant concern. The lack of complete and accurate claims (“encounter”) data for Medicare Advantage enrollees makes it difficult to compare service utilization and outcomes among beneficiaries in Medicare Advantage and traditional Medicare, nationally and by geographic region, plan characteristics, and beneficiary demographics. Many of the studies published since 2016 use relatively old data (i.e., data from before 2018) (50 of the 62 studies included in this literature review), which may not present an accurate reflection of current practices given how rapidly Medicare Advantage is growing.

Despite changes in Medicare Advantage enrollment patterns, gaps in research exist, particularly the experience among certain subgroups such as Black and Hispanic beneficiaries who are disproportionately enrolled in Medicare Advantage plans; beneficiaries living in rural areas; and high-need or medically complex segments of the population, such as beneficiaries under the age of 65 with long-term disabilities or beneficiaries with coverage under both Medicare and Medicaid. Additionally, despite being more than two years into the COVID-19 pandemic, we were unable to identify any studies that met our criteria and examined differences in COVID-19-related hospitalizations, deaths, vaccination rates, and treatments between Medicare Advantage and traditional Medicare beneficiaries.

This work was supported in part by Arnold Ventures. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

Back to top.

Back to top.

1. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
2. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
3. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
4. Sungchul Park et al., “Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias,” JAMA Network Open 3, no. 3 (March 2020): e201809, doi:10.1001/jamanetworkopen.2020.1809 ↩︎
5. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
6. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
7. Claire K. Ankuda et al., “Family and Friend Perceptions of Quality of End-of-Life Care in Medicare Advantage vs Traditional Medicare,” JAMA Network Open 3, no. 10 (October 2020): e2020345, doi:10.1001/jamanetworkopen.2020.20345 ↩︎
8. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
9. Laura Skopec, Joshua Aarons, and Stephen Zuckerman, “Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?” American Journal of Managed Care 25, no. 9 (September 2019): e261-e266, https://www.ajmc.com/view/did-medicare-advantage-payment-cuts-affect-beneficiary-access-and-affordability ↩︎
10. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
11. Laura Skopec, Joshua Aarons, and Stephen Zuckerman, “Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?” American Journal of Managed Care 25, no. 9 (September 2019): e261-e266, https://www.ajmc.com/view/did-medicare-advantage-payment-cuts-affect-beneficiary-access-and-affordability ↩︎
12. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
13. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
14. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
15. Kenton J Johnston, et al., “Comparison of Ambulatory Care Access and Quality for Beneficiaries with Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance,” JAMA Health Forum 3, no. 1 (January 2022): e214562, doi:10.1001/jamahealthforum.2021.4562 ↩︎
16. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
17. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
18. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
19. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
20. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
21. Laura Skopec, Joshua Aarons, and Stephen Zuckerman, “Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?” American Journal of Managed Care 25, no. 9 (September 2019): e261-e266, https://www.ajmc.com/view/did-medicare-advantage-payment-cuts-affect-beneficiary-access-and-affordability ↩︎
22. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
23. Michael T. Halpern ,Matthew P. Urato, and Erin E. Kent, “The health care experience of patients with cancer during the last year of life: Analysis of the SEER-CAHPS data set,” Cancer 123, no. 2 (January 2017): 336-344,  https://doi.org/10.1002/cncr.30319 ↩︎
24. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
25. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
26. Gretchen Jacobson et al., 2021 ↩︎
27. Gretchen Jacobson et al., 2021 ↩︎
28. Gretchen Jacobson et al., 2021 ↩︎
29. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
30. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
31. Marc N. Elliot et al., “Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts,” Health Affairs 35, no. 3 (March 2016): 456-463 https://doi.org/10.1377/hlthaff.2015.0816 ↩︎
32. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
33. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
34. Michael T. Halpern, Matthew P. Urato, Erin E. Kent, “The health care experience of patients with cancer during the last year of life: Analysis of the SEER-CAHPS data set,” Cancer 123, no. 2 (January 2017): 336-344,  https://doi.org/10.1002/cncr.30319 ↩︎
35. David Meyers et al., “Analysis of Drivers of Disenrollment and Plan Switching Among Medicare Advantage Beneficiaries,” JAMA Internal Medicine 179, no. 4 (February 2019): 524-532, doi:10.1001/jamainternmed.2018.7639 ↩︎
36. Claire Ankuda et al., “Switching Between Medicare Advantage And Traditional Medicare Before And After The Onset Of Functional Disability,” Health Affairs 39, no. 5 (May 2020), https://doi.org/10.1377/hlthaff.2019.01070 ↩︎
37. Sungchul Park, David Meyers, and Brent Langellier, “Rural Enrollees In Medicare Advantage Have Substantial Rates Of Switching To Traditional Medicare,” Health Affairs 40, no. 3 (March 2021), https://doi.org/10.1377/hlthaff.2020.01435 ↩︎
38. Claire Ankuda et al., “Switching Between Medicare Advantage And Traditional Medicare Before And After The Onset Of Functional Disability,” Health Affairs 39, no. 5 (May 2020), https://doi.org/10.1377/hlthaff.2019.01070 ↩︎
39. Sungchul Park et al., “Disease-Specific Plan Switching Between Traditional Medicare and Medicare Advantage,” The Permanente Journal 24 (November 2019), doi: 10.7812/TPP/19.059 ↩︎
40. Jeannie Fuglesten Biniek, Nancy Ochieng, Juliette Cubanski, and Tricia Neuman, Cost-Related Problems Are Less Common Among Beneficiaries in Traditional Medicare Than in Medicare Advantage, Mainly Due to Supplemental Coverage  (Washington, DC: KFF, June 2021), https://modern.kff.org/medicare/issue-brief/cost-related-problems-are-less-common-among-beneficiaries-in-traditional-medicare-than-in-medicare-advantage-mainly-due-to-supplemental-coverage/ ↩︎
41. Amy E. Cha & Robin A. Cohen, “Problems Paying Medical Bills, 2018,” National Center for Health Statistics Data Brief no. 357 (February 2020), https://www.ehidc.org/sites/default/files/resources/files/Problems%20Paying%20Medical%20Bills%202018.pdf ↩︎
42. Laura Skopec, Joshua Aarons, and Stephen Zuckerman, “Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?” American Journal of Managed Care 25, no. 9 (September 2019): e261-e266, https://www.ajmc.com/view/did-medicare-advantage-payment-cuts-affect-beneficiary-access-and-affordability ↩︎
43. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
44. Jeannie Fuglesten Biniek, Nancy Ochieng, Juliette Cubanski, and Tricia Neuman, Cost-Related Problems Are Less Common Among Beneficiaries in Traditional Medicare Than in Medicare Advantage, Mainly Due to Supplemental Coverage  (Washington, DC: KFF, June 2021), https://modern.kff.org/medicare/issue-brief/cost-related-problems-are-less-common-among-beneficiaries-in-traditional-medicare-than-in-medicare-advantage-mainly-due-to-supplemental-coverage/ ↩︎
45. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
46. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
47. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
48. Sungchul Park, Jose F. Figueroa, Paul Fishman, and Norma B. Coe, “Primary Care Utilization and Expenditures in Traditional Medicare and Medicare Advantage, 2007–2016,” Journal of General Internal Medicine 35 (May 2020): 2480-2481, https://doi.org/10.1007/s11606-020-05826-x ↩︎
49. Mireille Jacobson, Johanna Thunell, and Julie Zissimopoulos, “Cognitive Assessment At Medicare’s Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans,” Health Affairs 39, no. 11 (November 2020): 1935-1942, https://doi.org/10.1377/hlthaff.2019.01795 ↩︎
50. Mireille Jacobson, Johanna Thunell, and Julie Zissimopoulos, “Cognitive Assessment At Medicare’s Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans,” Health Affairs 39, no. 11 (November 2020): 1935-1942, https://doi.org/10.1377/hlthaff.2019.01795 ↩︎
51. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
52. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
53. Sungchul Park, Jose F. Figueroa, Paul Fishman, and Norma B. Coe, “Primary Care Utilization and Expenditures in Traditional Medicare and Medicare Advantage, 2007–2016,” Journal of General Internal Medicine 35 (May 2020): 2480-2481, https://doi.org/10.1007/s11606-020-05826-x ↩︎
54. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
55. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
56. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
57. Jose F. Figueroa et al., “Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure,” JAMA Cardiology 5, no. 12 (September 2020): 1349-1357, doi:10.1001/jamacardio.2020.3638 ↩︎
58. Zhuliang Tao et al., “Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population,” Vaccines 6, no. 4 (December 2018): 78, doi: 10.3390/vaccines6040078 ↩︎
59. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
60. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
61. Sungchul Park, Jose F. Figueroa, Paul Fishman, and Norma B. Coe, “Primary Care Utilization and Expenditures in Traditional Medicare and Medicare Advantage, 2007–2016,” Journal of General Internal Medicine 35 (May 2020): 2480-2481, https://doi.org/10.1007/s11606-020-05826-x ↩︎
62. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
63. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
64. Sungchul Park, Jose F. Figueroa, Paul Fishman, and Norma B. Coe, “Primary Care Utilization and Expenditures in Traditional Medicare and Medicare Advantage, 2007–2016,” Journal of General Internal Medicine 35 (May 2020): 2480-2481, https://doi.org/10.1007/s11606-020-05826-x ↩︎
65. Kenton J. Johnston, et al., “Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures,” JAMA 326, no. 7 (August 2021): 628-636, doi:10.1001/jama.2021.10413 ↩︎
66. Kenton J Johnston, et al., “Comparison of Ambulatory Care Access and Quality for Beneficiaries with Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance,” JAMA Health Forum 3, no. 1 (January 2022): e214562, doi:10.1001/jamahealthforum.2021.4562 ↩︎
67. Chima Ndumele et al., “Differences in Hospitalizations Between Fee-for-Service and Medicare Advantage Beneficiaries,” Medical Care 57, no. 1 (January 2019): 8-12, DOI: 10.1097/MLR.0000000000001000 ↩︎
68. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
69. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
70. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
71. Joseph P. Newhouse et al., “Delivery System Performance as Its Financial Risk Varies,” American Journal of Managed Care 25,  no. 12 (December 2019): e388-e394,  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412600/ ↩︎
72. Sungchul Park et al., “Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias,” JAMA Network Open 3, no. 3 (March 2020): e201809, doi:10.1001/jamanetworkopen.2020.1809 ↩︎
73. Aaron L. Schwartz et al., “Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis,” JAMA Health Forum 2, no. 12 (December 2021):e214001, doi:10.1001/jamahealthforum.2021.4001 ↩︎
74. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
75. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
76. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
77. Rachel Mosher Henke et al., “Medicare Advantage and Traditional Medicare Hospitalization Intensity and Readmissions,” Medical Care Research and Review 75 no. 4 (August 2018): 434-453, https://doi.org/10.1177%2F1077558717692103 ↩︎
78. Brian J. Moore and Lan Liang, Medicare Advantage Versus the Traditional Medicare Program: Costs of Inpatient Stays, 2009–2017 (Rockville, MD:  Agency for Healthcare Research and Quality, August 2020), https://www.ncbi.nlm.nih.gov/books/NBK562007/ ↩︎
79. Michael F Yayac, Samantha L Harrer, David A Janiec, and P Maxwell Courtney, “Costs and Outcomes of Medicare Advantage and Traditional Medicare Beneficiaries After Total Hip and Knee Arthroplasty,” Journal of the American Academy of Orthopaedic Surgeons 28, no. 20 (October 2020): e910-e916, DOI: 10.5435/JAAOS-D-19-00609 ↩︎
80. Qijuan Li et al., “Regional Variations: The Use Of Hospitals, Home Health, And Skilled Nursing In Traditional Medicare And Medicare Advantage,” Health Affairs 37, no. 8 (August 2018): 1274-1281, https://doi.org/10.1377/hlthaff.2018.0147 ↩︎
81. Aaron L. Schwartz et al., “Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis,” JAMA Health Forum 2, no. 12 (December 2021):e214001, doi:10.1001/jamahealthforum.2021.4001 ↩︎
82. Joan M. Teno et al. “Site of Death, Place of Care, and Health Care Transitions Among US Medicare Beneficiaries, 2000-2015,” JAMA 320 no. 3 (June 2018): 264-271, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076888/ ↩︎
83. Joan M. Teno et al., “Dying with dementia in Medicare Advantage, Accountable Care Organizations, or traditional Medicare,” Journal of the American Geriatrics Society 69, no. 10 (October 2021): 2802-2810, https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.17225 ↩︎
84. Sungchul Park, Joan M. Teno, Lindsay White, and Norma B. Coe, “Effect of Medicare Advantage on patterns of end-of-life care among Medicare decedents,” Health Services Research 57, no. 4 (February 2022): 863-871, https://doi.org/10.1111/1475-6773.13953 ↩︎
85. Qijuan Li et al., “Regional Variations: The Use Of Hospitals, Home Health, And Skilled Nursing In Traditional Medicare And Medicare Advantage,” Health Affairs 37, no. 8 (August 2018): 1274-1281, https://doi.org/10.1377/hlthaff.2018.0147 ↩︎
86. Sungchul Park et al., “Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias,” JAMA Network Open 3, no. 3 (March 2020): e201809, doi:10.1001/jamanetworkopen.2020.1809 ↩︎
87. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
88. Joseph P. Newhouse et al., “Delivery System Performance as Its Financial Risk Varies,” American Journal of Managed Care 25,  no. 12 (December 2019): e388-e394,  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412600/ ↩︎
89. Laura Skopec et al., “Home Health And Postacute Care Use In Medicare Advantage And Traditional Medicare,” Health Affairs 39 no. 5 (May 2020): 837-842, https://doi.org/10.1377/hlthaff.2019.00844 ↩︎
90. Peter Huckfeldt et al., “Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service,” Health Affairs 36, no. 1 (January 2017): 91-100, https://doi.org/10.1377/hlthaff.2016.1027 ↩︎
91. Jose F. Figueroa et al., “Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure,” JAMA Cardiology 5, no. 12 (September 2020): 1349-1357, doi:10.1001/jamacardio.2020.3638 ↩︎
92. Ying Cao et al., “Assessment of Differences in Inpatient Rehabilitation Services for Length of Stay and Health Outcomes Between US Medicare Advantage and Traditional Medicare Beneficiaries,” JAMA Network Open 3, no. 3 (March 2020): e201204, doi:10.1001/jamanetworkopen.2020.1204 ↩︎
93. Amit Kumar et al., “Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data,” Plos Medicine 15 no. 6 (June 2018): e1002592, https://doi.org/10.1371/journal.pmed.1002592 ↩︎
94. Michael F Yayac, Samantha L Harrer, David A Janiec, and P Maxwell Courtney, “Costs and Outcomes of Medicare Advantage and Traditional Medicare Beneficiaries After Total Hip and Knee Arthroplasty,” Journal of the American Academy of Orthopaedic Surgeons 28, no. 20 (October 2020): e910-e916, DOI: 10.5435/JAAOS-D-19-00609 ↩︎
95. Amit Kumar et al., “Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data,” Plos Medicine 15 no. 6 (June 2018): e1002592, https://doi.org/10.1371/journal.pmed.1002592 ↩︎
96. Ying Cao et al., “Assessment of Differences in Inpatient Rehabilitation Services for Length of Stay and Health Outcomes Between US Medicare Advantage and Traditional Medicare Beneficiaries,” JAMA Network Open 3, no. 3 (March 2020): e201204, doi:10.1001/jamanetworkopen.2020.1204 ↩︎
97. Peter Huckfeldt et al., “Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service,” Health Affairs 36, no. 1 (January 2017): 91-100, https://doi.org/10.1377/hlthaff.2016.1027 ↩︎
98. Emiley Chang et al., “Differences in Nursing Home Quality Between Medicare Advantage and Traditional Medicare Patients,” Journal of the American Medical Directors Association 17, no. 10 (October 2016): 960.e9-960e14, https://doi.org/10.1016/j.jamda.2016.07.017 ↩︎
99. Adrianne W. Casebeer et al., “A Comparison of Home Health Utilization, Outcomes, and Cost Between Medicare Advantage and Traditional Medicare,” Medical Care 60, no. 1 (January 2022): 66-74, https://doi.org/10.1097/MLR.0000000000001661 ↩︎
100. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
101. Sungchul Park et al., “Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias,” JAMA Network Open 3, no. 3 (March 2020): e201809, doi:10.1001/jamanetworkopen.2020.1809 ↩︎
102. Laura Skopec et al., “Home Health And Postacute Care Use In Medicare Advantage And Traditional Medicare,” Health Affairs 39 no. 5 (May 2020): 837-842, https://doi.org/10.1377/hlthaff.2019.00844 ↩︎
103. Lacey Loomer, Cyrus M. Kosar, David J. Meyers, and Kali S. Thomas, “Comparing Receipt of Prescribed Post-acute Home Health Care Between Medicare Advantage and Traditional Medicare Beneficiaries: an Observational Study,” Journal of General Internal Medicine 36 (October 2020): 2323–2331, https://doi.org/10.1007/s11606-020-06282-3 ↩︎
104. Laura Skopec et al., “Home Health Use In Medicare Advantage Compared To Use In Traditional Medicare,” Health Affairs 39, no. 6 (June 2020): 1072–1079, https://doi.org/10.1377/hlthaff.2019.01091 ↩︎
105. Daniel Waxman et al., “Does Medicare Advantage Enrollment Affect Home Healthcare Use?” American Journal of Managed Care 22, no. 11 (November 2016): 714-720, https://www.ajmc.com/view/does-medicare-advantage-enrollment-affect-home-healthcare-use ↩︎
106. Kali S Thomas et al., “Home Health Use Following a Cancer Diagnosis Among Patients Enrolled in Medicare Advantage and Traditional Medicare: Findings From the Newly Linked SEER-Medicare and Home Health OASIS Data,” JNCI Monographs 2020, no. 55 (May 2020): 53-59, https://doi.org/10.1093/jncimonographs/lgaa003 ↩︎
107. Stephen Zuckerman et al, Changes in Home Health Care Use in Medicare Advantage Compared to Traditional Medicare, 2011-2016 (Office of the Assistant Secretary for Planning and Evaluation, October 2020), https://aspe.hhs.gov/reports/changes-home-health-care-use-medicare-advantage-compared-traditional-medicare-2011-2016 ↩︎
108. Stephen Zuckerman et al., Changes in Home Health Care Use in Medicare Advantage Compared to Traditional Medicare, 2011-2016 (Office of the Assistant Secretary for Planning and Evaluation, October 2020), https://aspe.hhs.gov/reports/changes-home-health-care-use-medicare-advantage-compared-traditional-medicare-2011-2016 ↩︎
109. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
110. Kali S Thomas et al., “Home Health Use Following a Cancer Diagnosis Among Patients Enrolled in Medicare Advantage and Traditional Medicare: Findings From the Newly Linked SEER-Medicare and Home Health OASIS Data,” JNCI Monographs 2020, no. 55 (May 2020): 53-59, https://doi.org/10.1093/jncimonographs/lgaa003 ↩︎
111. Daniel Waxman et al., “Does Medicare Advantage Enrollment Affect Home Healthcare Use?” American Journal of Managed Care 22, no. 11 (November 2016): 714-720, https://www.ajmc.com/view/does-medicare-advantage-enrollment-affect-home-healthcare-use ↩︎
112. Laura Skopec et al., “Home Health Use In Medicare Advantage Compared To Use In Traditional Medicare,” Health Affairs 39, no. 6 (June 2020): 1072–1079, https://doi.org/10.1377/hlthaff.2019.01091 ↩︎
113. Qijuan Li et al., “Regional Variations: The Use Of Hospitals, Home Health, And Skilled Nursing In Traditional Medicare And Medicare Advantage,” Health Affairs 37, no. 8 (August 2018): 1274-1281, https://doi.org/10.1377/hlthaff.2018.0147 ↩︎
114. Stephen Zuckerman et al., Changes in Home Health Care Use in Medicare Advantage Compared to Traditional Medicare, 2011-2016 (Office of the Assistant Secretary for Planning and Evaluation, October 2020), https://aspe.hhs.gov/reports/changes-home-health-care-use-medicare-advantage-compared-traditional-medicare-2011-2016 ↩︎
115. Stephen Zuckerman et al., Changes in Home Health Care Use in Medicare Advantage Compared to Traditional Medicare, 2011-2016 (Office of the Assistant Secretary for Planning and Evaluation, October 2020), https://aspe.hhs.gov/reports/changes-home-health-care-use-medicare-advantage-compared-traditional-medicare-2011-2016 ↩︎
116. Daniel Waxman et al., “Does Medicare Advantage Enrollment Affect Home Healthcare Use?” American Journal of Managed Care 22, no. 11 (November 2016): 714-720, https://www.ajmc.com/view/does-medicare-advantage-enrollment-affect-home-healthcare-use ↩︎
117. Adrianne W. Casebeer et al., “A Comparison of Home Health Utilization, Outcomes, and Cost Between Medicare Advantage and Traditional Medicare,” Medical Care 60, no. 1 (January 2022): 66-74, https://doi.org/10.1097/MLR.0000000000001661 ↩︎
118. Daniel Waxman et al., “Does Medicare Advantage Enrollment Affect Home Healthcare Use?” American Journal of Managed Care 22, no. 11 (November 2016): 714-720, https://www.ajmc.com/view/does-medicare-advantage-enrollment-affect-home-healthcare-use ↩︎
119. Sungchul Park, Jose F. Figueroa, Paul Fishman, and Norma B. Coe, “Primary Care Utilization and Expenditures in Traditional Medicare and Medicare Advantage, 2007–2016,” Journal of General Internal Medicine 35 (May 2020): 2480-2481, https://doi.org/10.1007/s11606-020-05826-x ↩︎
120. Aaron L. Schwartz et al., “Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis,” JAMA Health Forum 2, no. 12 (December 2021):e214001, doi:10.1001/jamahealthforum.2021.4001 ↩︎
121. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
122. Sungchul Park et al., “Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias,” JAMA Network Open 3, no. 3 (March 2020): e201809, doi:10.1001/jamanetworkopen.2020.1809 ↩︎
123. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
124. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
125. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
126. Gretchen Jacobson, Aimee Cicchiello, Janet P. Sutton, and Arnav Shah, Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ? (Washington, DC: The Commonwealth Fund, October 2021), https://www.commonwealthfund.org/publications/issue-briefs/2021/oct/medicare-advantage-vs-traditional-medicare-beneficiaries-differ ↩︎
127. Joseph P. Newhouse et al., “Delivery System Performance as Its Financial Risk Varies,” American Journal of Managed Care 25, no. 12 (December 2019): e388-e394,  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412600/ ↩︎
128. Aaron L. Schwartz et al., “Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis,” JAMA Health Forum 2, no. 12 (December 2021):e214001, doi:10.1001/jamahealthforum.2021.4001 ↩︎
129. Kelly E. Anderson, Daniel Polsky, Sydney Dy, and Aditi P. Sen, “Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare,” Health Services Research 57, no. 3 (November 2021): 1-11, https://doi.org/10.1111/1475-6773.13912 ↩︎
130. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
131. Sungchul Park et al., “Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias,” JAMA Network Open 3, no. 3 (March 2020): e201809, doi:10.1001/jamanetworkopen.2020.1809 ↩︎
132. Sungchul Park, “Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness,” Health Services Research 57, no. 4 (February 2022): 820-829, https://doi.org/10.1111/1475-6773.13945 ↩︎
133. LC Baker, MK Bundorf, and DP Kessler, “The Effects of Medicare Advantage on Opioid Use,” Journal of Health Economics 70 (March 2020), doi: 10.1016/j.jhealeco.2019.102278 ↩︎
134. Zachary Levinson and Julia Adler-Milstein, “A decade of experience for high-needs beneficiaries under Medicare Advantage,” Healthcare 8, no. 4 (December 2020): 100490, https://doi.org/10.1016/j.hjdsi.2020.100490 ↩︎
135. Paul Jacobs and Jayasree Basu, “Medicare Advantage and Postdischarge Quality: Evidence From Hospital Readmissions,” American Journal of Managed Care 26, no. 12 (December 2020), https://www.ajmc.com/view/medicare-advantage-and-postdischarge-quality-evidence-from-hospital-readmissions ↩︎
136. Peter Huckfeldt et al., “Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service,” Health Affairs 36, no. 1 (January 2017): 91-100, https://doi.org/10.1377/hlthaff.2016.1027 ↩︎
137. Amit Kumar et al., “Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data,” Plos Medicine 15 no. 6 (June 2018): e1002592, https://doi.org/10.1371/journal.pmed.1002592 ↩︎
138. Daniel Jung et al., “Likelihood of hospital readmission in Medicare Advantage and Fee‐For‐Service within same hospital,” Health Services Research 55, no. 4 (August 2020): 587-595, https://doi.org/10.1111/1475-6773.13315 ↩︎
139. Maricruz Rivera-Hernandez, Momotazur Rahman, Vincent Mor, and Amal N. Trivedi, “Racial disparities in readmission rates among patients discharged to skilled nursing facilities,” Journal of the American Geriatrics Society 67 no. 8 (August 2019): 1672-1679, doi: 10.1111/jgs.15960 ↩︎
140. Laura Skopec et al., “Home Health And Postacute Care Use In Medicare Advantage And Traditional Medicare,” Health Affairs 39 no. 5 (May 2020): 837-842, https://doi.org/10.1377/hlthaff.2019.00844 ↩︎
141. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
142. Amit Kumar et al., “Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data,” Plos Medicine 15 no. 6 (June 2018): e1002592, https://doi.org/10.1371/journal.pmed.1002592 [cxlii] Daniel Jung et al., “Likelihood of hospital readmission in Medicare Advantage and Fee‐For‐Service within same hospital,” Health Services Research 55, no. 4 (August 2020): 587-595, https://doi.org/10.1111/1475-6773.13315 ↩︎
143. Maricruz Rivera-Hernandez, Momotazur Rahman, Vincent Mor, and Amal N. Trivedi, “Racial disparities in readmission rates among patients discharged to skilled nursing facilities,” Journal of the American Geriatrics Society 67 no. 8 (August 2019): 1672-1679, doi: 10.1111/jgs.15960 ↩︎
144. Peter Huckfeldt et al., “Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service,” Health Affairs 36, no. 1 (January 2017): 91-100, https://doi.org/10.1377/hlthaff.2016.1027 ↩︎
145. Laura Skopec et al., “Home Health And Postacute Care Use In Medicare Advantage And Traditional Medicare,” Health Affairs 39 no. 5 (May 2020): 837-842, https://doi.org/10.1377/hlthaff.2019.00844 ↩︎
146. Daniel Jung et al., “Likelihood of hospital readmission in Medicare Advantage and Fee‐For‐Service within same hospital,” Health Services Research 55, no. 4 (August 2020): 587-595, https://doi.org/10.1111/1475-6773.13315 ↩︎
147. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
148. Paul Jacobs and Jayasree Basu, “Medicare Advantage and Postdischarge Quality: Evidence From Hospital Readmissions,” American Journal of Managed Care 26, no. 12 (December 2020), https://www.ajmc.com/view/medicare-advantage-and-postdischarge-quality-evidence-from-hospital-readmissions ↩︎
149. Yue Li et al., “Medicare Advantage Associated With More Racial Disparity Than Traditional Medicare For Hospital Readmissions,” Health Affairs 36, no. 7 (July 2017): 1328-1335, https://doi.org/10.1377/hlthaff.2016.1344 ↩︎
150. Michael F Yayac, Samantha L Harrer, David A Janiec, and P Maxwell Courtney, “Costs and Outcomes of Medicare Advantage and Traditional Medicare Beneficiaries After Total Hip and Knee Arthroplasty,” Journal of the American Academy of Orthopaedic Surgeons 28, no. 20 (October 2020): e910-e916, DOI: 10.5435/JAAOS-D-19-00609 ↩︎
151. Joobong June Park Oh, “Analysis of Hospital Readmission Patterns in Medicare Fee-for-Service and Medicare Advantage Beneficiaries,” Professional Case Management 22, no. 1 (January/February 2017): 10-20, doi: 10.1097/NCM.0000000000000172 ↩︎
152. Rachel Mosher Henke et al., “Medicare Advantage and Traditional Medicare Hospitalization Intensity and Readmissions,” Medical Care Research and Review 75 no. 4 (August 2018): 434-453, https://doi.org/10.1177%2F1077558717692103 ↩︎
153. Rachel Mosher Henke et al., “Medicare Advantage and Traditional Medicare Hospitalization Intensity and Readmissions,” Medical Care Research and Review 75 no. 4 (August 2018): 434-453, https://doi.org/10.1177%2F1077558717692103 ↩︎
154. Joobong June Park Oh, “Analysis of Hospital Readmission Patterns in Medicare Fee-for-Service and Medicare Advantage Beneficiaries,” Professional Case Management 22, no. 1 (January/February 2017): 10-20, doi: 10.1097/NCM.0000000000000172 ↩︎
155. Michael F Yayac, Samantha L Harrer, David A Janiec, and P Maxwell Courtney, “Costs and Outcomes of Medicare Advantage and Traditional Medicare Beneficiaries After Total Hip and Knee Arthroplasty,” Journal of the American Academy of Orthopaedic Surgeons 28, no. 20 (October 2020): e910-e916, DOI: 10.5435/JAAOS-D-19-00609 ↩︎
156. Yue Li et al., “Medicare Advantage Associated With More Racial Disparity Than Traditional Medicare For Hospital Readmissions,” Health Affairs 36, no. 7 (July 2017): 1328-1335, https://doi.org/10.1377/hlthaff.2016.1344 ↩︎
157. Orestis A. Panagiotou et al., “Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis,” Annals of Internal Medicine 171, no. 2 (July 2019): 99-106, doi: 10.7326/M18-1795 ↩︎
158. Maricruz Rivera-Hernandez, Momotazur Rahman, Vincent Mor, and Amal N. Trivedi, “Racial disparities in readmission rates among patients discharged to skilled nursing facilities,” Journal of the American Geriatrics Society 67 no. 8 (August 2019): 1672-1679, doi: 10.1111/jgs.15960 ↩︎
159. Yue Li et al., “Medicare Advantage Associated With More Racial Disparity Than Traditional Medicare For Hospital Readmissions,” Health Affairs 36, no. 7 (July 2017): 1328-1335, https://doi.org/10.1377/hlthaff.2016.1344 ↩︎
160. Maricruz Rivera-Hernandez, Momotazur Rahman, Vincent Mor, and Amal N. Trivedi, “Racial disparities in readmission rates among patients discharged to skilled nursing facilities,” Journal of the American Geriatrics Society 67 no. 8 (August 2019): 1672-1679, doi: 10.1111/jgs.15960 ↩︎
161. Yue Li et al., “Medicare Advantage Associated With More Racial Disparity Than Traditional Medicare For Hospital Readmissions,” Health Affairs 36, no. 7 (July 2017): 1328-1335, https://doi.org/10.1377/hlthaff.2016.1344 ↩︎
162. William B. Weeks et al., “Ambulatory Care Sensitive Condition Admission Rates in Younger and Older Traditional Medicare and Medicare Advantage Populations, 2011–2019,” Journal of General Internal Medicine 18 (June 2021), https://doi.org/10.1007/s11606-021-06955-7 ↩︎
163. Sungchul Park et al., “Racial Disparities in Avoidable Hospitalizations in Traditional Medicare and Medicare Advantage,” Medical Care 59 no. 11 (November 2021):989-996, doi:10.1097/MLR.0000000000001632 ↩︎
164. Sungchul Park et al., “Racial Disparities in Avoidable Hospitalizations in Traditional Medicare and Medicare Advantage,” Medical Care 59 no. 11 (November 2021):989-996, doi:10.1097/MLR.0000000000001632 ↩︎
165. David Meyers et al., “Comparison of the Quality of Hospitals That Admit Medicare Advantage Patients vs Traditional Medicare Patients,” JAMA 3 no. 1 (January 2020): e1919310, doi:10.1001/jamanetworkopen.2019.19310 ↩︎
166. Daeho Kim et al. “Comparison of the Use of Top-Ranked Cancer Hospitals Between Medicare Advantage and Traditional Medicare,” The American Journal of Managed Care 27, no. 10 (October 2021): https://www.ajmc.com/view/comparison-of-the-use-of-top-ranked-cancer-hospitals-between-medicare-advantage-and-traditional-medicare ↩︎
167. Margot Schwartz et al., “Quality of Home Health Agencies Serving Traditional Medicare vs Medicare Advantage Beneficiaries,” JAMA 2 no. 9 (September 2019): e1910622, doi:10.1001/jamanetworkopen.2019.10622 ↩︎
168. Laura Skopec et al., “Home Health Use In Medicare Advantage Compared To Use In Traditional Medicare,” Health Affairs 39, no. 6 (June 2020): 1072–1079, https://doi.org/10.1377/hlthaff.2019.01091 ↩︎
169. David J. Meyers, Vincent Mor, and Momotazur Rahman, “Medicare Advantage Enrollees More Likely To Enter Lower-Quality Nursing Homes Compared To Fee-For-Service Enrollees,” Health Affairs 37, no. 1 (January 2018): 78-85, https://doi.org/10.1377/hlthaff.2017.0714 ↩︎
170. Emiley Chang et al., “Differences in Nursing Home Quality Between Medicare Advantage and Traditional Medicare Patients,” Journal of the American Medical Directors Association 17, no. 10 (October 2016): 960.e9-960e14, https://doi.org/10.1016/j.jamda.2016.07.017 ↩︎
171. Jose F. Figueroa et al., “Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure,” JAMA Cardiology 5, no. 12 (September 2020): 1349-1357, doi:10.1001/jamacardio.2020.3638 ↩︎
172. Jose F. Figueroa et al., “Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices,” JAMA Cardiology 4, no. 3 (February 2019): 265-271, doi:10.1001/jamacardio.2019.0007 ↩︎
173. Sungchul Park et al., “Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare,” Medical Care 58, no. 11 (November 2020): 1004-1012, doi: 10.1097/MLR.0000000000001390 ↩︎
174. Bruce E. Landon, Alan M. Zaslavsky, Jeffrey Souza, and John Z. Ayanian, “Use of Diabetes Medications in Traditional Medicare and Medicare Advantage,” The American Journal of Managed Care 27, no. 3 (March 2021), https://www.ajmc.com/view/use-of-diabetes-medications-in-traditional-medicare-and-medicare-advantage ↩︎
175. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
176. Elham Mahmoudi, Wassim Tarraf, Brianna L. Maroukis, and Helen G. Levy, “Does Medicare Managed Care Reduce Racial/Ethnic Disparities in Diabetes Preventive Care and Healthcare Expenditures?” American Journal of Managed Care 22, no. 10 (October 2016): e360-e367, https://www.ajmc.com/view/does-medicare-managed-care-reduce-racial-ethnic-disparities-in-diabetes ↩︎
177. Brian W. Powers et al., “The Beneficial Effects Of Medicare Advantage Special Needs Plans For Patients With End-Stage Renal Disease,” Health Affairs 39, no. 9 (September 2020): 1486-1494, https://doi.org/10.1377/hlthaff.2019.01793 ↩︎
178. Justin W. Timbie et al., “Medicare Advantage and Fee‐for‐Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States,” Health Services Research 52, no. 6 (December 2017): 2038-2060, doi: 10.1111/1475-6773.12787 ↩︎
179. Sungchul Park et al., “Trends in Use of Low-Value Care in Traditional Fee-for-Service Medicare and Medicare Advantage,” JAMA Network Open, 4 no. 3 (March 2021): e211762, doi:10.1001/jamanetworkopen.2021.1762 ↩︎
180. Sungchul Park et al., “Trends in Use of Low-Value Care in Traditional Fee-for-Service Medicare and Medicare Advantage,” JAMA Network Open, 4 no. 3 (March 2021): e211762, doi:10.1001/jamanetworkopen.2021.1762 ↩︎
181. David Meyers et al., “Analysis of Drivers of Disenrollment and Plan Switching Among Medicare Advantage Beneficiaries,” JAMA Internal Medicine 179, no. 4 (February 2019): 524-532, doi:10.1001/jamainternmed.2018.7639 ↩︎
182. Aaron L. Schwartz et al., “Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis,” JAMA Health Forum 2, no. 12 (December 2021):e214001, doi:10.1001/jamahealthforum.2021.4001 ↩︎